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FTIR  Fourier Transform – Infra Red Spectroscopy 
SEM  Scanning Electron Microscopy 
ICP-OES Inductively Coupled Plasma Optical Emission-Spectrometry 
LD Low Dose 
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BDL  Below Detection Limit 
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INTRODUCTION 
 
 Medicine is not merely a science but an art as well.  The science of medicine 
is important to man’s well being and survival.  Siddha system is considered to be one 
of the traditional system of medicine with prestigious background of Tamil culture.  
Siddha is a complete holistic medical system that was founded by the siddhars. 
 The word ‘siddha’ comes from the word ‘siddhi’ which means an object to be 
attained or perfection or heavenly bliss.  Siddhi generally refers to astama siddhi (ie) 
eight super natural powers.  Which are enemurated as anima, mahima, lagima etc.  as 
mentioned in silappathigaram.  Those who achieved the above said powers are known 
as “Siddhars”. 
 Siddhars are those who lived and maintained their bodies as they desired best.  
They were most of  Tamil Saiva sect which maintained siva for its God, and rejected  
everything else.  They are the greatest men holding tremendous powers in themselves 
by way of yoga practice and rejuvenation.  They attained spiritual awakening by 
rousing, with their suppressed breathing, kundaline (Serpent power as it termed), 
lying dormant at the base of the spinal column, 
 Siddha system emphazies not only a healthy body but also sound mind and 
soul.  The predominant aim of siddha science is to assure the full span of long healthy 
life to enable man acquire knowledge, cultivate good characters and conduct with 
which they could enjoy their legitimate worldly pleasures and ultimately attain 
salvation. 
 The universe is made up of five basic elements viz.  Earth, water, fire, Air and 
space which are also present in human.  Alteration of this basic elements in human 
body leads to vitiation of three humours.  Siddha system of medicine is mainly based 
on this three humoral theory namely vatham, pitham and kapham are in definite 
proportions 1: ½ : ¼ respectively.  Any alteration in this ratio of humor cause disease 
in human body. 
 In siddha system of medicine understanding the human body mechanism starts 
from the knowledge of cosmogenensis.  The nature and humans are interrelated.  The 
elements exist in the universe exist in human. 
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 “n{<mk<kqZt<tOk!hq{<ml<< < < < << < < < << < < < <!
! ! hq{<mk<kqZt<tOk!n{<ml<< < < < << < < < << < < < <!
! n{<mLl<!hq{<mLl<!ye<Ox< < < < << < < < << < < < < !
! ! !nxqf<Kkie<!hiIg<Gl<OhiOk< < < << < < << < < < !
. sm<mLeq!Riel<< << << <!
Siddhar’s massered alchemy and prepared medicine from plant, metal, 
minerals and animal kingdom mainly for rejuvenation of the body, which will help to 
attain salvation through good healthy life. 
In siddha system, initally herbal preparation should be used for treatment, 
according to prognosis then metallic & mineral preparation should be given, this is 
portrated in the below lines, 
 “Oui<hiV!kijphiV!lqR<sqeg<giz<!olz<zolz<z< < < < < << < < < < << < < < < < !
! hx<h!osf<K~vl<!hiOv< < << < << < < ” 
    -Agathiyar pin -80 
Though siddha system of medicine are traditionally practised in south India.  
Further development and distribution of siddha system medicine, standardization 
methods of drugs are to be done. 
With growth of science and development of scientific methods of research, 
treatment of diseases now relies largely on evidence based medicines.  Rigorous steps 
are followed and care is exercised in the introduction of new drugs. 
  As a part of standardization toxicity study is important.  This ensures the 
safety therapeautic dose of a drug. 
 Toxicology is the science dealing with property, action, toxicity of a 
substance.  “All drugs are poison- it is only the dose which makes a thing a poison”.  
This statement by Paracelsus hold good even today.  And also the same concept is 
revealed in tamil leterature as 
 “ntUg<G!lqR<sqeiz<!nlqi<kLl<!fR<S< < < < < << < < < < << < < < < < ”!
. hpolipq!
lx<Xl<!
! “hQzqohb<!sigiMl<!ns<sqXl<!nh<h{<ml<Q < < < < < < <Q < < < < < < <Q < < < < < < <!
! siz!lqGk<K!ohbqe<< << << <”!
! ! ! ! .kqVg<Gxt<< << << <!
Though siddha physician’s wonder about their remedies with their medicines.  
We lack in scientific validation of the drug and misconception of other form of 
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medical practitioner, that is contains crude metal and mineral preparation which are 
said to be toxic. 
In order to eradicate these misconception of siddha system, toxicity study over 
the drugs are important. 
Toxicological screening is very important for the development of new drugs, 
extention of therapeautic potential of the existing molecule.  They are mostly used to 
examine specific adverse effect.  It also helps to calculate the no observed adverse 
effect level (NOAEL) dose and is helpful for clinical trials. 
The drug “SANGU PARPAM’ prepared as per text book of Gunapadam 
thathu-jeeva vaguppu, indicated for Maradaippu, Nenchu vali, Marppu erichal, 
Neersurukku, Vellai.  I have chosen the above formulate drug for toxicological 
evaluation as my dissertaion work. 
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AIM AND OBJECTIVE 
 
AIM 
 The aim of this study is to evaluate the toxicity study on “SANGU PARPAM” 
 
Objective 
 To collect and purify the raw materials  based on literature evidence. 
 To perform compound analysis for the purified raw drug samples. 
 To prepare the medicine based on siddha literature evidence. 
 To estimate the presence of chemical constituents by performing elemental 
analysis.  
To analyse its safety, the medicine is subjected for acute oral toxicity 
evaluation on rodents when the drug is given in single dose through oral 
administration at various dose levels. 
 To analyse its safety, the medicine is subjected for repeated oral dose 
(subacute) toxicity study evaluation on rodents when the drug is given for 28 days.
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SIDDHA LITERATURE REVIEW 
sr<G<<< !
!sr<G! Jl<ohVl<! gmz<hM! kqvuqbr<gtqz<! ye<X! we! sqxh<hqg<gh<hMgqxK/!!
-h<H,Uzgqz<! &e<xqz<! -V! hGkqjbg<! ogi{<cVg<Gl<! gmz<?! flg<G! kVl<!
osz<ur<gt<! g{g<gqzmr<gi/! weqEl<?! sqzujg! ohiVm<gt<! fl<! fim<Mg<G!
ohVl<HgjpBl<?! sqxh<jhBl<?! nf<fqb! oszui{qjbBl<! ohx<X! kVueuig!
-Vg<gqe<xe/!
-bx<jgbigOu! flg<G! gqjmg<Gl<! &zh<ohiVm<gTg<Gk<! kqvuqbl<! we<X!
ohbi</! ! ! klqpi<gt<! -bx<jgh<! ohiVm<gjtg<! gmz<hM! kqvuqbl<?! giMhM!
kqvuqbl<?!fiMhM!kqvuqbl<?!ljzhM!kqvuqbl<!we<X!nu<uh<hGkqbqz<!gqjmk<kqMl<!
sqxh<hie!ohiVm<gjt!ujgh<hMk<kqh<!hqiqk<Kt<tei</!
Jl<ohVl<!kqvuqbr<gt<!we!sqxh<hqg<gh<hMhju/!
sr<G?!Lk<K?!hutl<?!dh<H?!yg<Ogijz!-ju!gmz<hM!kqvuqbr<gtqz<!
ujgh<hMk<kh<hm<Mt<te/!
klqpi<gt<! Np<gmzqz<! &p<gq! sr<G! wMk<kjzBl<?! Lk<K! Gtqk<kjzBl<!
fl<! klqpg! lg<gt<! hz! F~X! N{<MgTg<G! Le<eOv! nxqf<K! nke<! upq!
ohVjlh<!ohx<xui<gtiuiIgt</!!dzgqOzOb!Lk<KgjtBl<?!sr<GgjtBl<!hx<xq!
Lke<Lkzig!nxqf<kui<gt<!klqpi<gt<!weqz<!nK!lqjgbe<X/!!Nsqb!hGkqgt<!
nkqZl<! -f<kqb! ohVr<gmz<! hGkqbqz<! sr<G! ujggt<! nkqglig! gqjmg<gh<!
ohXgqxK/!
leqke<! ke<! Gpf<jk! hVuk<kqz<! sr<G! hizijmbqz<! hiz<! nVf<Kukqz<!
okimr<gq?! nuEjmb! -Xkq! bik<kqjvbqz<! sr<ogizqg<g! nmr<GuK! ujv?!
nueK! uip<uqe<! hz! fqjzgtqz<! sr<G! yV! ! siqk<kqvl<! hjmk<kqVg<gqxokeqz<!
nK! lqjgbqz<jz/! ! “sr<G”! fl<! klqpgk<kqz<! lm<MOl! lqg! nkqg! ntuqz<!
gqjmg<gg<%cb!gmz<hM!ohiVtiGl</!
sr<G! ujggjt! lg<gt<! Heqkh<! ohiVtigUl<?! H,jsh<! ohiVtigUl<?!
lVf<Kh<! ohiVtigUl<! hbe<hMk<kq! uVgqe<xei</! sr<gqe<! fQI! hiuk<jk! fQg<g!
uz<zK! nkqz<! jug<gh<hMl<! hiz<! sf<kkqbx<x! oh{<gTg<G! Hk<kqvh<! Ohx<jx!
ntqg<guz<zK/!
Ohigi<!givsivk<Kjx!71!z<!sr<G!hR<sH,k!dhvsk<kqz<!nh<H!H,kg<%xig!
%xh<hm<Mt<tK/!
“osiz<zg<Og!Thvsk<kqe<!Hkf<!ke<jes<< < < < < < << < < < < < << < < < < < <!
! osiz<ZgqOxil<!H,figl<!vis!ui<k<kl<< < < < < << < < < < << < < < < <!
olz<zg<Og!th<hqvg!&sqg<!gif<kl<< < < < < << < < < < << < < < < <!
! Olzie!sqzisk<Kl<!H,lq!bis<S< < << < << < < !
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Hz<zg<Ogt<!f{<Mfk<jk!sr<G!Lm<jm< < < < < < << < < < < < << < < < < < < !
! ohix<gqtR<sq!zqjujbf<Kl<!HeOz!biGl<< < < < << < < < << < < < <!
gz<zg<Ogt<!out<jtg<gz<!-f<kqvOgihl<< < < < < < < << < < < < < < << < < < < < < <!
! gPjku{<M!fqlqjtbk<kq!gez<%xiOl< < << < << < < ”/!
!
OuXohbi<gt<< << << <!
! gl<H?!OgiM?!sr<G?!sr<gl<?!Sk<kq?!SiqLgl<?!ff<K?!fiG?!Okukk<kl<?!
h{qzl<?!-ml<Hiq?!uzl<Hiq?!ujt?!out<jt?!kvi?!u{<M?!uiv{l</!
!
sm<mLeq!fqg{<M< << << <   
!! g{<mgs<!sr<G?!guovP!sr<gl<?!dbe<x!ouzs<sr<G?!dOvilk<kqe<!sr<G/!!
!
Ohigi<!fqg{<M!< << << < .2311!
! kutl<?!kqjmfikl<?!ujt?!uiVkqeikl<?!uzl<Hiq?!-ml<Hiq?!sqe<el<?!
h{qzl<?!szl <Hiq?!hm<sq?!gl<H?!szR<szl<?!fQr<gik!OuijsObie</< < < < < Q < << < < < < Q < << < < < < Q < < !
! “sr<gqEm!Ohi<kjeOb!six<xg<OgT< < < << < < << < < < !
! ! kut!lif<kqseikl<!ujtbliGl<< < << < << < <!
! ur<gqeqm!uzl<Hiqbilqml<!HiqBliGl<< < < << < < << < < <!
! ! uiVkqbq!eikf<kie<<< <!sqe<eliGl<< < << < << < <!
! fr<gqeqm!sr<giGl<!h{qzl<!hi{q< < < << < < << < < < !! !
! ! fzlie!szl<HiqBl<!hm<sqgl<H< < < << < < << < < < !
! sr<sqeqm!fQr<gik!Ouijs!Obieil<< Q < << Q < << Q < <!
! ! szR<sziliR<!sr<gqeqm!fil!liOl< < << < << < < ” 
!
!! lr<gtlblie! -e<hk<jk! uqVl<Hgqe<xui<gTg<G! uqVl<hqbjkk<!
ogiMh<hkiz<!“gl<H”!we<El<!ohbi<!ohx<xK!we<hi</!
! sr<G!gmz<uip<!dbqiqeole<hkiz<!“\Que<”!we<x!ohbVl<!umolipqbqz<!
d{<M/!
!
ujggt<;<<< !
!! sr<Ggtqe<! sqxf<k! ujggjtg<! Gxqh<hqMl<ohiK! klqp<! fqg{<MgTl<?!
umolipq! F~z<gTl<! nux<jx! -ml<Hiq?! uzl<Hiq?! szR<szl<?! hiR<sse<eqbl<!
we<X!fiz<ujgh<hMk<kqBt<te/!
!
! “-h<hq!NbqvR<!$p<f<kK!< < < << < < << < < < yV!-ml<Hiqobe<Xl<< < << < << < <!
! -ml<Hiq!NbqvR<!$p<f<kK!yV!uzl<Hiqobe<Xl<< < < < < < << < < < < < << < < < < < <!
! uzl<Hiq!NbqvR<!$p<f<kK!yV!szR<szl<!we<Xl<< < < < < < < << < < < < < < << < < < < < < <!
! szR<szl<!NbqvR<!$p<f<kK!yV!hiR<s!se<eqbl<< < < < < < < << < < < < < < << < < < < < < <”!
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we<Xl<!%xh<hMgqe<xK/!
!
2/ szR<szl<!)YI!sr<G*!a conch shell of super eminent quantities valute syrum.!
3/ Lm<sr<G!–!Prickly chank one with thorn like points.!
4/ hm<c!nz<zK!sqXsr<G!
5/ Gx<sr<G?!chank containing or Impregnated with pearls.!
6/ kipR<!sr<G?!One with a wide mouth.!
7/ uzl<Hiq!sr<G?!One with spiral opening to the right, chank shell of happy 
convolutions (upqhim<cx<Giqb!de<ekh<!ohiVt<!NBt<?!osz<ul<?!
lg<gm<OhX!ohVGl</!
8/ -ml<Hiq!sr<G!–!Ordinary chank with an opening to the left.!
9/ hizijms<!sr<G!–!Small conch used for giving milk to children.!
:/ dui<s<sr<G!
21/ fQIuip<!sr<G?!conch shell turbinella raps .!
22/ Lt<Ts<sr<G!
23/ hix<sr<G?!white chank!
24/ ou{<sr<G!
25/ hs<js!sr<G!
26/ DK!sr<G!
27/ gqV]<{!sr<G!the conch worn by vishnu!
28/ kQIk<k!sr<G?!sacred conch shell!
29/ uiqs<sr<G?!striped conch!
2:/ hiR<s!se<eqbl<?!Yi<uqk!sr<G!
31/ oki{qs<sr<G!
32/ gmx<sr<G?! a large convolute shell regarded as religious!
33/ g{<mgs<!sr<G?!a thorny chank in the sacred  
Gandhaka river near Banaras.!
34/ Ogizss<!sr<G!
!
ohiKg<G{l<< << << <!
! “gsqui!lqvk<k!hqk<kr<!g{<O{ibg!OtGl<< < < < << < < < << < < < <!
! hsqbiXl<!uikl<!hxg<G!< < << < << < < –!lqsqUmOe!
! kr<G!Ljt!uqv{f<!kiegZ!Olout<jts<< < < << < < << < < <!
! sr<glK!U{<mibqx<xie<< < < << < < << < < <”/!
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!! ou{<sr<gqeiz<! -vk<khqk<kl<?! g{<O{ib<gt<?! uik! lqGkq?! -sqU?!
Ljtg<gm<c!Lkzqbe!fQr<Gl</!!hsq!d{<miGl</!
osb<jg<<< !
 dmz<!dvlig<gq!
 Kbvmg<gq!
 ngm<M!uiBgx<xq!
 hsqk<kQk<K~{<c!
 KuIh<hq!
 ouh<hgx<xq!
 Ogijpbgx<xq!
Sk<kq<<< !
! yV!ohiVtqz<!dt<t!fs<S!ke<jljb!fQg<gq!njk!lVf<kigUl<?!dmzqz<!
ose<X!Osi<ukx<G!WKuigUl<!osb<uK!Sk<kq!LjxbiGl</!
!
sr<G!Sk<kq< << << < !
! gx<S{<{il<Hl<!dui<l{<[l<!sloujm!%m<c?!w{<lmr<G!fQI!Osi<k<K!
oktqouMk<K?!nkqz<!sr<jgh<!Ohim<M!wiqk<Kg<!gPuq!wMg<g!Sk<kqbiGl</!
!
hqxSk<kq!Ljxgt<< << << <!
2/ yV! hzl<! sr<gqx<G! 6! hzl<! -jzg<gt<tqs<! six<jxg<! gijzbqz<! uqm<M!
lijz!ujv!oub<bqzqz<!dzi<k<kq?!lXfit<!gijzbqZl<!Hkqkig!Olx<hc!
six<jx! uqm<M! oub<bqzqz<! jug<gUl</! ! -r<rel<! OlZl<! &e<XLjx!
osb<K!fQI!uqm<M!gPuqobMg<gs<!Sk<kqbiGl</!
3/ Lm<sr<jg!hVlie!K{<Mgtigs<!osb<K!k{<{Qiqz<!nz<zK!-tfQiqz<!
NXl{q!Ofvl<!Dx!juk<Ks<!osl<jlbig!nzsq!nkqZt<t!l{<!
Lkzqbjugjt!fQg<gq!uqMuOk!Sk<kqbigl</!
4/ sr<jg!gx<S{<{il<hqz<!Hjkk<K!kitqk<K!gPuq!wMg<g!Sk<kqbiGl</!
!
sr<G!OsVl<!hqx!lVf<Kgt<< < < << < < << < < <!
2/sr<G!hx<hl<!)hqxLjxgt<*< < < << < < << < < < !
Okjubie!svg<Ggt<< << << <!
2/!Sk<kqk<k!osb<k!sr<G<<< !
3/!dk<kil{q!-jz!
osb<Ljx!<<< !
!! gx<S{<{il<hqeiz<!Sk<kqosb<k!sr<jg?!dk<kil{q!-jzuqPkqz<!
Hjkk<Kg<!geHmlqmh<!hx<hliGl</!
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ntU!
! 3!Ge<xq!)371!lq/gqvil<*!ujv!
Kj{lVf<K<<< !
ofb<!
kQVl<Ofib<gt<Q < < <Q < < <Q < < <!
!! -Vlz<?!&zl<?!ubqx<Xh<hq{q?!n{<{ig<Gk<!K~X?!)Enlarged tonsils) liIH!
uzq?!uiB!Ge<ll</!
3/!sr<Ghx<hl< << << < <!)hqxLjxgt<*<<< !
Okjubie!svg<Ggt<< << << <!
2/ Sk<kq!osb<k!sr<G<<< !
3/ kiljv!-jz!
osb<Ljx<<< !
! Sk<kq!osb<k!sr<gqx<Gk<!kiljv!-jz!uqPjkh<!H,sq!yVfit<!oub<bqzqz<!
dzi<k<kq!geHmlqm<omMg<gh<!hx<hliGl</!
ntU!!
! Lk<kqetU!
Kj{lVf<K!<<< !
!! ofb<!
kQVl<Ofib<gt<Q < < <Q < < <Q < < <!
! g{<Hjgs<sz<?!g{<!-Vt<?!hqk<kl<!Lkzqbe?!dmZg<G!fqxL{<miGl</!
!! -h<hx<hk<jk!Ktsqs<six<xqz<!ogiMg<g?!ghk<jkk<!Okcg<ogi{<cVg<gqe<x!
sf<kq?!okif<kqk<k!fim<hm<m!Svl<!Ngqbe!fQr<Gl</!
!
4/!sr<G!osf<K~vl<< < << < << < <!
! sr<G<<< !?!out<jt!Oujts<siX?!gx<xijps<siX!-v{<jmBl<!ogi{<M!
keqk<keqbib<!njvk<K!Ljxh<hc!Hmlqm<omMg<gs<!osf<K~vlil</!
! “fk<jk!Osi{qk!lig<gOu< << << < !
! ! fuqe<x!Olx<hc!obie<xqOz< < << < << < < !
sk<kq!Gli<<< q!bqv{<cOz<<< !
kV{!uve<Ljx!Okm<cOb< << << < !
uqk<jk!bVjl!bxqf<Ok!osb<< < << < << < <!
! Ouk!upqbqz<!F~e<jlbib<< < << < << < <!
lqk<v!Ohk!lqz<zilz<< < << < << < <!
! Oum<jg!bxqf<K!osb<uQOv< < < Q< < < Q< < < Q ” 
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!
osf<K~vk<kqeiz<!kQVl<!Ofib<gt<!Kj{lVf<KgTl<!
Kj{lVf<K<<< !! ! kQVl<Ofib<gt<Q < < <Q < < <Q < < <!
out<jt!Oujts<siX! dm<m{!Olgl<!
sf<keg<Gpl<H!! ! uikl<!
dt<tqvsl<! ! ! SOuk!sf<kq?!hqk<kOfib<!
sil<hqvi{qbqjzs<siX! uQg<gh<hi{<M!
wZlqs<sl<hpvsl<! ! ou{<Gm<ml<!
ouz<zl<! ! ! Ge<l!lKOlgl<!
fiuz<hpvsl<! ! ! 'huqgivk<!Oklz<?!Olgl<!
-zur<gh<hm<jms<siX! sf<kqOkimg<!GtqIjl!
!
5/!sr<G!S{<{l<< < << < << < <!
! ohVl<! sr<jgg<<< <! gz<Zvzqz<! -ck<K! K{qbqz<! ucgm<c! wZlqs<sl<!
hps<six<jx! uqm<M! yV! sill<! Ofvljvk<K! uqz<jz! osb<K! fe<xib<! dzi<k<kq!
ngzqz<! juk<K! OlOziM! &c! -v{<M! sQjz! l{<! osb<K! gusk<kqe<! wjmg<G!
31!hr<G!wjm!uxm<cbqz<!Hmlqm<M!Nxqbhqe<!wMg<gh<hm<m!sr<gieK!S{<{ligq!
-Vg<Gl</!!-kqz<!Olx<g{<m!wjm!fqXk<K!wMk<Kg<!ogit<t!Ou{<cbK/!
! S{<{k<jk! keqbigOu! dhObigqg<gzil<?! -kx<G! hi{<M?! fQIg<gm<M?!
fQIg<Ogiju?!lR<st<!Ofib<!Ngqbju!kQVl</!
!
6/!out<jt!lik<kqjv< << << < !
! hupl<?! hiz<Kk<kl<?! sQeigivl<?! ohiiqk<k! KVS! -jugt<! ujgg<G! yV!
uvigoejmBl<! sr<G<<< ! uvigoejm! -Vhk<K! fie<Gl<! )211/9! gqvil<*! wMk<K!
fQIuqm<Mg<! gPuq?! dzi<f<khqe<! K~t<! osb<K! gz<uk<kqzqm<Mk<! kib<h<hiz<!
njvg<giz<hc! )279! lqzq*! uqm<mjvk<K! nke<hqe<! -tfQI! giz<hc! )447! lq/zqm<mi<*!
uqm<mjvk<K!olPGh<hkk<kqz<!lik<kqjvgtib<k<!kqvm<c!dzi<k<kqg<!ogit<tUl</!
!
Kj{lVf<Kgt<< << << <!
! Sk<kfQI!nz<zK!Ljzh<hiz<!
!
kQVl<Ofib<gt<Q < < <Q < < <Q < < <!
! -vk<kh<hmzl<!Lkzqb!g{<O{ib<gt<!
!
Gxqh<H<<< !
! -l<lik<kqjvjb!YI!N{<M!gpqk<K!dhObigqk<kz<!Ou{<Ml</!
!
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7/!sf<kqOvikb!lik<kqjv< << << < !
! Sk<kqosb<k!sr<G<<< !3!½!hzl<?!-kje!yV!uvm<cbqe<!lQK!hvh<hq!juk<K!
nke<! lQK! yV! uvm<cjb! juk<K! 211! hzl<! uvm<cbqx<! Hmlqm<M! Nxqe!
hqe<oeMk<Kg<!ogit<tUl</!!-h<hcs<!osb<ukiz<!sr<G!njv!Oug<gimibqVg<Gl</!!
LP! Oug<gimig! Ou{<Mole<hK! nusqblqz<jz/! ! %Mlieiz<! OuX! wf<k!
uqkligqZl<! sr<jg! njv! Oug<gimig! Sm<Mg<! ogit<t! Ou{<cbK/! -u<uqkl<!
njvOug<gimigs<! Sm<m! sr<G! hx<hl<! .! 2! hr<G! K~b<jl! osb<K! dzi<k<kqb!
ohiiqk<Kh<!ohick<k!fim<M!ou{<givk<!K~t<!¼!hr<G?!Ljzh<hiz<!osz<zk<kg<g!
ntU/!
!
osb<Ljx<<< !
! Le<! g{<m! &e<X! svg<GgjtBl<! gz<uk<kqzqm<M! Ljzh<hijz!
sqXgs<sqXg! uiIk<K! yV! sill<! njvk<K! yV! Ge<xql{q! wjm! ntU!
lik<kqjvgt<!osb<K!fqpzqZzi<k<kq!juk<Kg<!ogit<tUl</!
!
ntU!
! 2!Lkz<!3!lik<kqjv!
!
Kj{lVf<K<<< !
! Ljzh<hiz<?!Oke<?!he<eQI?!gsgsig<!GcfQI!
!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <!
! Svl<?!-Vlz<?!Gpf<jkgtqe<!Ofib<?!hqk<k!sl<hf<klie!Ofib</!
!
8/!wzqg<gcg<Gg<!Ogimg!sijz!w{<o{b<< < < < << < < < << < < < <!
!
sr<G<<< ! ! ! uq]<[gqvf<kq!
Ogimgsijz!! Ogiju!
uQpqOui<! ! osf<fiBVuq!Oui<!
jgbif<kgjv!! Hr<gl<!Oui<!
gim<Mlz<zqjg! oum<hijz!-jz!
-Zh<jhOui<! ! out<Ouz<!
&g<gvm<jm!Oui<! kqVGgt<tq!Oui<!
nLg<gqvig<!gqpr<G! ofis<sqOui<!
gx<$jv!Oui<!! lqtgvj{!Oui<!
hqv{<jm!Oui<! uqti!
ogie<jeh<hm<jm! dgiOui< 
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kqh<hqzq! ! uqz<uh<hk<kqiq!
H,{<M!! ! Ogi]<ml<!
osr<gPfQIg<gqpr<G! gMg<gib<k<Okiz<?!!sQvgl<!
!! -jugjt! ujgg<G! 2! uvigoejm! )5/3! gqvil<*! uQkolMk<K! fe<xig!
-ck<K! fz<oz{<o{Bme<! )4! Osi<! / 8.40 gqvil<*! gzf<K! nMh<hqe<! OlOzx<xq!
wiqk<Ks<!squf<k!hkk<kqz<!-xg<gq!ucg<gUl</!
! -f<k! w{<o{bqz<! yV! Km<omjm! obMk<K! dm<ogit<tUl</! ! wzq!
gck<keiOzx<hm<m!uq]r<gt<!kQVl</!
!
9/!fbe!Ovigk<kqx<G!lik<kqjv< < << < << < < !
 gmz<Fjv!
 sr<G<<< !)Sm<mK*!
 Osipq!)Sm<mK*!
 lqtG!
 Okx<xie<!uqk<K!)sQuqbK*!
-jugjts<!sllig!wMk<Kh<!Ohb<g<gVh<hR<!six<xqeizjvk<K!
lik<kqjvbigk<!kqvm<c?!fqpzqZzi<k<kq!Ljzh<hizqjpk<K!g{<{qzqm!31!
uVmr<gt<!ose<x!H,Ul<!liXl</!
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Phyllanthus amarus 
gQpiofz<zqQ <Q <Q < !
!
!
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gQpiofz<zqQ <Q <Q < !
OuXohbi<<<<!
• gQp<g<gib<ofz<zq!
• gQp<uib<!ofz<zq!
! “oktquie!bug<gz<!oue<Xl<!OhV< < < << < < << < < < !
! ! kqVuil<!hz!oue<xkx<Gh<!OhV{<mis<S< < < < < << < < < < << < < < < < !
! gequie!sr<g{im<c!oue<Xl<!OhV< < < << < < << < < < ! !
! ! siIuie!slf<kikiq!obe<Xl<!OhV< < << < << < < !
! ogitquie!Ogizu!fQk!ole<Xl<!OhVQ < <Q < <Q < < !
! ! %Ihjm!kjv!obie<hm!oujzuR<sq!obe<Xl<!OhV< < < << < < << < < < !
! /////////////////////////////////////////////////////////////////////////!
!! nug<gz<?! kqVuil<hz<?! sr<g{im<c?! slf<kikqiq?! OgizufQkp<?! %Ihjm?!
kjvobie<hmz<?!wjznR<sq!NgqbjuBl<!
! gQpi!ofz<zqbqe<!OQ < <Q < <Q < < hjvg<!%xg<OgT< << << < !
! ! gqtqIs<sqbie<!klqzgi!klvuQkq< < Q< < Q< < Q !
! lipikli!zf<Kli!zqeqbi<!liki< << << < !
! ! lzg<gqsk<K!OuzqbiGl<!hiV< < << < << < < !
! Ohpig!ogMHk<kqviki!hziuib<< << << <!
! ! ohVjlbil<!H,kik<kqiq!ohVuqiqb!giuir<< < << < << < <!
! kipik!gilijz!fqui<k<kbiGl<< < << < << < <!
! ! gim<sqbiz<!gQpiofz<zq!g{g<GliOl/< < Q < << < Q < << < Q < < !
. hR<sgiuqb!fqg{<M!911< << << < !
!! klqzgi?! klve<?! lizf<K?! lizqeqbi<?! liki! we<hjuBl<! gQpiofz<zqbqe<!
OuX!ohbi<gtiGl</!
!
ujggt<<<<!
 gQp<g<gib<!ofz<zq!
 osr<gQpiofz<zq!
 Olz<gQpiofz<zq!
 um<MgQpiofz<zq!
!
utVlqml<<<<!
-f<kqbiuqz<!ouh<h!fiMgtqz<!sKh<hie!wz<zi-mr<gtqZl<!utVl</!
!
hbe<hMl<!dXh<H< < << < << < < !
s&zl<!
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Sju!
 -eqh<H!
 Htqh<H!
 jgh<H!
 KuIh<H!
ke<jl<<< !
! ouh<hl<!
hqiqU!
! -eqh<H!
osb<jg<<< !
 uQg<gLVg<gq!
 sqXfQIohVg<gq!
 Kui<h<hq!
 Gtqi<s<sqB{<mig<gq!
ohiKg<G{l<< << << <!
! sQklkq!hqk<kuqmR<!osu<uqpqbqe<!Ofib<g<%m<ml<Q < < < < < < < <Q < < < < < < < <Q < < < < < < < <!
! H,koliM!Ohbqvk<kh<!Ohig<GgTl<!< < < << < < << < < < .!H,kzk<Kt<< << << <!
! kip<uib<h<!h{qk<OkGh<!kh<hiK!ohib<bzOu< < < < < < << < < < < < << < < < < < < !
! gQp<uQ <Q <Q < i!obE!ofz<zqg<Og/< << << < !
! gQpiofz<zqg<G{k<kie<!Ogtib<!lKOlgf<Q < < < < < <Q < < < < < <Q < < < < < <!
! kipig<gi!lijzgjt!s{<[f<ki!< < << < << < < –!OkpeZf<<<<!
! okig<gqje!Zf<okijzg<Gf<!okie<Olgl<!Ohig<gquqmf<< < < < < < < << < < < < < < << < < < < < < <!
! kg<guqv!{r<ogMg<Gf<!kie<< < < < << < < < << < < < <!
. G{himl<!&zqjg!uGh<H< << << < !
!! gQpiofz<zbqeiz<!ubqx<X!lf<kl<?!kQg<Gx<xk<kiz<!uqjtf<k!OgM?!g{<{qz<!
Okie<Xl<! Ofib<g<%m<mr<gt<?! GVkqg<gpqs<sz<?! fQiqpqU?! gilijz?! dmzqz<!
d{<miGl<! ouh<H?! dmzqz<! Okxqb! Olgl<?! sh<kkiKgk! Svl<?! kiKouh<hl<?!
fim<hm<m!Olgh<H{<!Ngqb!-ju!OhiGl</!
! OlZl<! -0K! nSk<k! vk<kl<?! uqpqOfib<?! fiuxm<sq?! kigl<! -jugjtBl<!
fQg<Gl</!!uikk<jkh<!ohVg<gs<!osb<Bl</!
!
!
!
!
!
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gQpiofz<zq!OsVl<!hqx!lVf<Kgt<Q < < < <Q < < < <Q < < < <!
2/hR<s!ogtuqbg<!gqVkl<< < << < << < <!
! hSuqe<hiz<!
ofb<!
OgifQI!
kbqi<!!
si{l<!! .!ujgg<G!hc!3!)3/7!zqm<mi<*!
nkqlKvl<! ! sqXOkg<G!
Ogi]<ml<! ! -f<Kh<H!
uib<uqtr<gl<!! keqbi!
uqpziqsq! ! uiZPjubiqsq!
oum<hijzniqsq! usl<H!
out<Tt<tq! ! OkukiV!
skGh<jh! ! sqx<xvk<jk!
sf<kel<! ! gVR<sQvgl<!
gVuih<hm<jm!! fe<eiiqOui<!
ohie<LSm<jm! ofz<zqlvOui<!
sivj{Oui<! ! gQpiofz<zqQ <Q <Q < !
fqzh<hjeg<gqpr<G! Kk<kqOui<!
GOvisi{q!Yll<! ohVGVh<jh!
nkquqmbl<! ! sikqg<gib<!
-zur<gh<hk<kqiq! kqiqgMG!
uqz<uOui<!sil<hz<! gMg<gib<!
kie<xqg<gib<! ! ofz<zqux<xz<!! .!ujgg<G!gpR<S!2!)6/2!gqvil<*!
Lkzqz<!-v{<M!hc!)3.7zq*!ntU!hSuqe<!si{k<kqz<!3!hcbtU!nke<!
sqXfQjv! uqm<M! gjvk<Kh<! hqjsf<K! ucgm<c! hiz<?! kbqi<?! ofb<! -l<&e<jxBl<!
%m<c! yV! gqVk! hi{<mk<kqz<! juk<Kg<! ogit<g/! ! nh<hiz<! 3uK! nr<gk<kqz<!
Gxqh<hqm<m! 47! svg<GgjtBl<! fe<G! dzi<k<kq! -ck<Kk<! $v{qk<Kh<! hSuqe<hiz<!
uqm<M! fe<G! njvk<K! Le<Sk<kh<hMk<kq! juk<Kt<t! gqVkhi{<mk<kqz<! Ohim<Mg<!
gjvk<K!nMh<hqOzx<xq!kqel<!sqXkQbig!¼! .!½!!! )7.23!fqlqml<*!sill<!wiqk<K!
nMh<OhiM!juk<K!uqMg/!!-h<hc!3!fit<!wiqk<K!4uK!fit<!hkLxg<!gib<s<sq!
ucgm<c!juk<Kg<!ogit<tUl</!
ntU!
! Oujtg<G!2.3!Okg<gv{<c!)5.9!lqzq*!ntU!kqel<!3!Oujt!ogiMk<K!
uVg/!
! !
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kQVl<Ofib<gt<Q < < <Q < < <Q < < <!
! ohVl<hiM?!Ge<ll<?!hQfqsl<?!gilijz?!ohVubqX?!hi{<M!
hk<kqbl<< << << <!
! Htqh<H?!jgh<H!fQg<gq!-s<sihk<kqbl<!fe<X/!
. g{<[silq!hvl<hjv!juk<kqbl<!hg</362< < < < << < < < << < < < < !
!
3/gilijz!gqbipl<<<<!
!
! gQpiofz<zqQ <Q <Q < !
! giqszir<g{<{q!
! Ohb<h<Hmz<!
! ou{<lqtG!
! Osil<H!
! uqz<uOui<!
ujgg<G!hzl<!¼!)21/3gq*!uQkl<!-ck<K!yV!GMjubqz<!Ohim<M!½!hc!)761lqzq*!
szl<!uqm<M!¼!hcbig!)436!lqzq*!S{<mg<!gib<s<sq!ucgm<c!Oujtg<G!2!
nUe<^ <!)41lqzq*!uQkl<!4!Oujt!dm<ogit<tUl</!!-h<hc!4.6!fit<!dm<ogit<t!
hi{<M?!Osijg?!gilijz!Lkzqb!Ovigr<gt<!Ohil</!
!
. hkiIk<k!G{sqf<kil{q!&zui<g<gl<!hg<< < < < < << < < < < << < < < < <.362!
!
gzqg<g!lik<kqjv< << << < !
!
! YMGR<!se<eq!&Is<js!obiM!
! ! dt<Ot!Suis!Olicuqcz<!
! YMr<Ogiz<!gzqg<gl<!fbek<kq!
! ! ozz<zi!uqbikq!uqmr<g!Tg<Gl<!
! kMr<Gl<!uqiqs<sie<!ogil<lm<c!
! ! kgjv!uqjvBr<!gQp<uqk<Kl<Q < < <Q < < <Q < < <!
! uqMr<Ogiz<!lqtG!KiqS!Kk<kl<!
! ! out<tq!uqjvBl<!sQeq!lqm<Om/!
! -m<Om!bjvg<g!Ohb<h<hQIg<g!
! ! eqjzbil<!uz<zqs<!six!jxk<K!
! gm<Om!Gtqjg!fqpZ!zi<k<kq!
! ! g{<{q!uqMl<!Ofvlkqz<!
! km<Om!Gtqjg!obie<Ox!Mk<K!
! ! sx<Ox!Bh<Hr<!Gh<jh!Oleq!
!
19 
 
! uqm<Om!gsg<gq!g{<{qzqm!
! ! uq{<{qz<!Ohie!Ubqi<lQTl</!
. ngk<kqbi<!juk<kqb!gi{<ml<!h/w{</!:1< < < < < << < < < < << < < < < < !
Okjubie!svg<Ggt<< << << <!
2/ ogil<lm<c!uqjk!
3/ kgjv!uqjk!
4/ gQp<gib<!ofz<zqQ < < <Q < < <Q < < < !uqjk!
5/ lqtG!
6/ KiqS!)Sk<kqk<kK*!
7/ Kk<kl<!)Sk<kqk<K*!
8/ out<tiq!uqjk!
9/ sQeq! ! ! ! ! slntU!
:/ Ohb<hQIg<G!-jzs<siX!
21/ hqv{<jms<siX! ! ! Okjubie!ntU!
!
osb<Ljx<<< !
! w{<!2!Lkz<!9!ujvBt<t!svg<Ggjt!ye<xib<!Osi<k<K!gz<uk<kqzqm<M?!
Ohb<h<hQIg<G!-jzs<siX!lx<Xl<!hqv{<jms<six<xiz<!njvk<K!lik<kqjv!osb<K!
fqpzqz<!dzi<k<kq!jug<gUl</!
!
hbe<hMk<Kl<!Ljx< < << < << < < !
! sqxqktU!dh<H!Osi<k<Kh<!hqpqf<k!Gh<jhOleq!six<xqz<!lik<kqjvjb!
-jpk<Kg<!g{<{quqmUl</!
!
kQVl<!Ofib<Q < <Q < <Q < <!
! se<eq!Ofibiz<!Wx<hMl<!&Is<js!kQVl</!
!
5/!figvs!hx<hl<< << << <!
Okjubie!svg<Ggt<< << << <!
2/ figl<!Sk<kqk<kK!–!46!gqvil<!
3/ gQpiofz<zqQ <Q <Q < !!s&zl<!sqX!K{<Mgtig!fXg<gqbK/!
4/ hjelm<jm!GVk<Ks<!siX!
5/ -vsl<!Sk<kqk<kK/!
osb<Ljx<<< !
!! figk<jk! -Vl<Hg<gmibqz<! -m<M! ge<eie<! djzbqz<! juk<K! dVg<gq?!
sqXK{<Mgtig! fXg<gq! juk<kqVg<Gl<! gQp<g<gib<! ofz<zq! s&zk<jk! sqxqktU!
K~uq! gv{<cbiz<! Okb<g<gilz<! figk<jkg<! gqtxq! uqmUl</! lQ{<Ml<! KVk<kqjb!
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uqjsbig! Dkq?! lQkLt<t! K{<Mgjtk<! K~uq?! gqtxqg<ogiMg<gh<hx<xq! wiqf<K!
H,g<Gl</! ! -kje! olz<zqb! sQjzbqz<! u^<kqvgibl<! osb<K! kqh<hqgjtk<! kt<tq?!
H,k<kqVh<hjkg<! gz<uk<kqzqm<M?! nf<k! wjmg<G! -vsl<! Osi<k<K! hjelm<jmg<!
GVk<Ks<! six<xiz<! he<eqov{<M! l{q! Ofvl<! njvk<K! uqz<jzk<! km<cg<!
gibjuk<K!Ym<czqm<M!sQjzl{<!osb<K?!gib<f<k!hqe<!hk<K!nz<zK!hkqjef<K!
uvm<cbqz<!Hmlqm<M!wMk<K?!njvk<K!juk<Kg<!ogit<tUl</!
ntU!
! 41.61!lq/gqvil<!?!3!Oujt!
!
nEhiel<<<<!
! hSofb<!nz<zK!hSou{<o{b<!
!
hk<kqbl<< << << <!
! -s<sihk<kqbl<!
!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <!
! &zOfib<gt<?!hUk<kqv!Ofib<gt<?!out<jt?!Olguqv{l</!
. sqgqs<sivk<fQkQhl<?!higl<!.!II hg<gl<w{</325!
!
6/!gQpiofz<zq!GcfQi<Q < Q <Q < Q <Q < Q <!
Okjubie!ohiVm<gt<;< << << < !
2/ gQpiofz<zqsQ <Q <Q < <!s&zl<!
3/ lR<st<giqsijz!
4/ out<tim<M!HPg<jg!
5/ Nl{g<G!Oui<!
6/ Sg<G!
7/ Lmg<gx<xie<!Oui<!
osb<Ljx;<<< !
!! Olx<osiz<zh<hm<m!NX!ohiVm<gjtBl<!ujgg<G!yV!gpR<S!)6!gqvil<*!
uQkl<!wMk<kg<!GcfQi<!osb<K!gijz?!!lijz!-VOujtBl<!Hgm<c!uv!
lR<sm<gilijz!kQVl</!
hk<kqbl<;< << << < !
!! hiZl<!OsiX!
!! G{k<okiM!gQpi!ofz<zqQ <Q <Q < !
! ! %xohix<!xjzg<jg!biE!
! l{k<kout<!tim<M!zk<kq!
! ! uti<f<kui!l{g<G!Sg<G!
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! hj{k<kqM!Lmg<gx<xiEl<!
! ! higlib<g<!GcfQi<!ogi{<miz<!
! -j{k<klR<!sm<gi!lijz!
! ! ObVl<hi!ze<er<!ogit<Ot!
!
7/!gQpiofz<zq!w{<o{b<Q < < <Q < < <Q < < <!
Okjubie!svg<Ggt<;< << << < !
2/ Nl{g<G!ofb<!yV!hc!!)!2/4zq*!
3/ hSl<hiz<!yV!hc!
4/ gQpiofz<zqs<Q < <Q < <Q < <!siX!njvg<giz<!hc!!)!271!zqm<*!
5/ nkqlKvl<!
6/ uqm<[!gqvif<kqOui<!
7/ gMg<gib<k<!Okiz<!
8/ kie<xqg<gib<!Okiz<!
9/ Ktsqbqjz!
:/ K~Kujt!Oui<!
21/ hsjvg<gQjv!
22/ Okiz<!sQuqe!Sg<G!
23/ -tfQi<!
!
osb<Ljx;<<< !
!! yV! hc! Nl{g<G! ofb<?! yV! hc! hSl<hiz<?! ! Npig<G! 271! lq/zq!
gQpiofz<zqs<siX?! ! Ngqb! -l<&e<jxBl<! yV! l{<! sm<cbqz<! Dx<x! Ou{<Ml</!
nkqlKvl<?! uqm<[gqvif<kqOui<?! gMg<gib<k<Okiz<?! kie<xqg<gib<! Okiz<?! ! Okiz<!
sQuqe! Sg<G?! Ktsqbqjz?! K~Kujt! Oui<?! hsjvg<gQjv! Ngqb! -u<oum<Mh<!
ohiVt<gjtBl<! ujgg<G! yV! hz<! uQkl<! wMk<K?! nkqz<! OhiKlie! -tfQi<!
uqm<mjvk<K! Olx<osie<e! w{<o{Bme<! %m<cg<! gzf<K! wiqk<Kh<! hg<Gulig!
uck<K!wMg<g!Ou{<Ml</!
hbe<<<<!
!! njk! -vU! d{uqx<Gh<hqe<! yV! ds<sqg<gv{<cbtU! ogiMk<K! dxr<gs<!
osb<b!Ou{<Ml<!nh<hcs<!osb<b!gijzbqz<!OhkqbiGl<!nkeiz<!-Vlz<?!g{l<?!!
wZl<jhh<hx<xqb! Svl<?! dm<Svl<?! ! ubqx<Xg<gMh<H?! ! uvm<g{l<?! ! &zg<g{l<!
Lkzqb!Ofib<gt<!fQr<Gl</!
! !
22 
 
8/!gQpiofz<zqh<hiz<Q < < <Q < < <Q < < <!
!
Okjubie!svg<Ggt<;< << << < !
2/ gQpiofz<zqQ <Q <Q < !!Oui<h<hm<jm!
3/ gxqOuh<hqjz!
4/ sQvgl<!
5/ hs<js!ofz<Zlq!
6/ kib<h<hiz<!
7/ lqtG!
!
!! gQpiofz<zqQ <Q <Q < !Oui<h<hm<jm?!gxqOuh<hqjz?!sQvgl<?!hs<js!ofz<Zlq?!-f<fie<G!
svg<GgjtBl<! ujg<G! yV! uvigoejm! )5/3gqvil<*! wMk<K! -ck<K! njk!
kib<h<hizqz<! Ohim<M! YiqvU! LPuKl<! Dxjuk<K! lXfit<! gijz! njvk<Kh<!
hqpqf<K! ogiMg<g! Ou{<Ml</! ! gijzbqz<! lm<Ml<! &e<X! fim<gTg<G! -jkg<!
ogiMg<g!Ou{<Ml</!
! lijzbqz<!hk<K!lqtjgs<!sil<hzig<gq?!sQvgl<!njv!uvigoejm!)3gqvil<*!
wMk<Kh<! ohiiqbzqm<M! ! 91! lq/zq/! fQi<! uqm<M! -v{<M! ogikq! uf<kUme<! ucgm<c!
ogiMg<g!Ou{<Ml</!!-u<uqkl<!osb<K!uv!g{Ofib<!G{liGl</!
!
upg<GLjxgt<< << << <!
! -tr<ogiPf<jkg<!GcfQiqm<Ms<!sQkg<!gpqs<sZg<Gg<!ogiMg<gzil</!
-jzjb!dh<H!Osi<k<kjvk<Ks<!osixq?!!sqvr<GgTg<G!H,s!-ju!OhiGl</!
! -jzjb!njvk<K!kjss<!sqjkUg<G!hx<xqmzil</!
! -h<H,{<ce<!-jzjbBl<!OuVl<!fQr<gzig?!lx<x!k{<Mgjt!wMk<Ks<!siX!
hqpqf<K! uqtg<og{<o{bqz<! gzf<K! g{<gis! OfiBjmObiIg<Gg<! g{<{qz<!
uqmUl</!
! -jzjbBl<! OujvBl<! dzi<k<kq! ohick<K?! gPfQiqz<! Gjpk<K!
H{<HjvgTg<Gl<!uQg<gr<gTg<Gl<!H,szil</!
! -jzjbBl<! OujvBl<! GcfQiqm<M! Svr<gTg<Gs<! $m<OmiOm! ogiMg<g!
gib<s<sz<!k{qBl</!
! -kjeOb! NxqbhqxG! Gck<K! uv! dmz<! uZg<Gl</! ! -K! hsqk<kQjb!
K~{<Ml</!
! -jz?! Oui<! Lkzqbux<jx! njvk<K! Oliiqz<! gzg<gqg<! ogiMk<Kuiqe<?!
lR<sm<gilijz?!OlgOfib<!-jugt<!Ohil</!!dh<H!fQg<gUl</!
! Oujvg<gPfQiqz<!njvk<Kg<!gzg<gqh<!ohVl<him<cx<Gg<!ogiMg<g!SgliGl</!
! Oujvh<!hs<jsbib<!28!gqvil<!wMk<K!njvk<K?!hizqz<!gzg<gqg<!ogiMg<g!
gilijz!Ofib<!fQr<Gl</!
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MODERN ASPECT 
CONCH SHELL 
 Man has close relation with mollusca since prehistoric times.  The mysterious 
creation of the nature from marine source fascinated man and with time the man 
attributed magical and mythical powers to shells and started crafting monuments.  The 
excavation of stone age cultures found to contain heaps of discarded shells in kitchen.  
There exists evidence for the shell trade between prehistoric Iran and southern Asia. 
 A large number of molluscs species are found in India.  Molluscs constitute an 
important component of marine biodiversity of India.  It is estimated that number of 
molluscs species varies between 80,000 and 1,00,000.  There are five kinds of 
molluscs species found in India.  Out of 586 families found in the world, 279 families 
were present in India. 
 Among the molluscs, chanks is the most important species.  Chanks are 
commercial importance due to their varied and unique structure, large size and 
glittering surface when polished. 
 The history of chank can be dates back to Indus valley civilization.  Chank 
ornaments were also found in excavations of Mohenjadaro and Harapa.  According to 
Tamil literature, chank cutting industry existed 2000 years ago.  Though it declined in 
TamilNadu.  it is still a flourishing industry in west Bengal, orissa and Bangladesh. 
 They are used as ornaments like bangles, rings, necklace and variety of shell 
crafts.  They are also used amulet against evil eye. 
 Chank blowing is usual custom to announce auspicious, religious and sacred 
events also to last rites.  It is blown to invocate God at the time of worship.  Water 
poured from a chank is considered as ‘holy’ according to Hindu religion. 
 
VERNACULAR NAMES 
Tamil  : Sangu, sankas 
English : Conch shell, conch 
Sanskrit : Shankha 
Bengali : Sankh 
Telugu : : Sankhamu  
Kannada : Shankha  
Hindi  : Shanke 
Malayalam : Sangu 
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Zoological classification 
Kingdom : Animalia 
Phylum : Mollusca 
Class  : Gastropoda 
Family  : Turbinellidae 
Sub family : Turbinellinae 
Genus  : Turbinella 
Species : pyrum 
 
Morphology of chank 
 Chanks has a large, massive, elegant shell with a fine pear shaped spire and a 
wide opening or mouth which is prolonged into a narrow spout. 
 Chanks has an external lustrus yellowish brown horny layer and beneath it a 
thick layer, chiefly formed of calcium salts. 
 
Valampuri chank 
 Chanks are characterized by large shells with fine texture and are highly 
valued.  Normally, the chanks shell are formed in a dextral spiral; occasionally shells 
with a sinistral spiral are also formed.  This peculiar type of chank is called 
“valampuri chank’.  These have a high value and very rarely caught, almost one in a 
lakh. 
 A sinistral chank is very rare and considered very auspicious and deeply 
venerated by Hindus. 
  Busycon contratrium is found very common in gulf of mexico and west florida 
is imported to India and sold as sacred chank at higher cost. 
 
Action 
 Nutrient 
 Anodyne 
 Carminative 
 Stomachic 
 Astringent 
 Febrifuge 
 Expectorant 
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Uses of chank 
Therapeutic benefits 
 The shells were used to cure many ailments in many countries for years 
together. 
a. A remedy for pimples and other skin troubles on the face and body. 
b. Internally given for acute form of dyspepsia. 
c. Shooting pain and inflammatory condition in the joints. 
d. Shell grit is used in production of dental cream, talcum powder, carbide 
industry. 
e. Chank powder is a panacea for many illnesses like jaundice, general debility, 
cough. 
f. Dried visceral mass is efficient in enlargement of spleen. 
g. Incase of Rickets, chank powder mixed with water is rubbed on the breasts. 
h. Given for asthma, cough, constipation 
i. Used in head ache, general debility and eye diseases. 
Industries like national Institute of oceanography like goa, central drug 
research Institute in lucknow.  Bose Institute of oceanography in kolkata are 
concered with development of marine medicinal products. 
- (Krishnamoorthy K.Sanga illakiyathil sangu, Unnamalai 
publication, chidabaran). 
  Apart from the above medicinal uses, chanks are also made in bangles, 
bracelets, rings etc,. These are some of the zoological aspect and uses of the ancient 
people. 
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KEEZHANELLI 
Botanical name 
 Phyllanthus amarus 
 
Classification 
Kingdom - Plantae 
Division - Angiosperm 
Class  - Dicotyledons 
Sub-class - Monochlamydeae 
Series  - Unisexuales 
Family  - Euphorbiaceae 
Genus  - Phyllanthus 
Species - amarus 
 
Regional and Other Names 
Bengali - Bhui amla 
English - Country gooseberry 
Gujarati - Bhonyaanmali 
Hindi  - Jarmla, bhonyabali 
Kannada - Nela nelli 
Malayalam - Kirganellia 
Marathi - Bhuiavali 
Sanskrit - Bhudhatri 
Tamil  - Kilanelli 
Telugu  - Nela usivika 
 
Habitat 
 Perennial erect herb 
 
Distribution 
 It is chiefly distributed in tropical and subtropical regions of the world except 
australia. 
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Habit & Features 
 A herb upto 60cm in height occuring as a winter weed.  Stem angular, leaves 
distichous elliptic oblong or linear oblong, flower axillary, yellowish, greenish or 
whitish male flowers 1-3 female solitary; capsules 2.5mm diameter depressed – 
globose, smooth, sarcely lobed, seeds 3 gonous, pale brown, longitudinally ribbed. 
 
Morphology 
Stem 
 Stem often branched at the base angular leaf bearing branch lets-slendes 
spreading. 
Leaves 
 Leaves closely arranged upto 1.5x0.6cm, obtuse or retuse at apex, petiole 
1.5cm stipules lanceolate 1mm. 
Flowers 
 Flowers are yellowish green in minute cymules, pendant from the axils of 
leaves. 
Male flower 
 Tepals 5 to 6, obovate, stamens 3, anthers sessile on the short column, 
filaments connate. 
Female flower 
 Tepals much shorter than capsule, 1.2mm long, style 3, capsule oblate, 
smooth. 
Seeds 
 Seeds 1.5mm long, 6 in number, blackish, concentrically striate. 
Chemical constituents 
 The major chemical constituent are lignans diaryl butane, phyllanthin and aryl 
tetrahydronapthelene, hypophyllanthin. 
 Ent-norsecuriniae, seco-4-hydroxylintetralin, seco-isolariciresmol-trimethyl 
ether, hydroxyni anthin seed contains oil which contains-linoteic & linolenic acid. 
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 The chemical constituents are 
Chemical Part 
3, 5, 7- Trihydroxy flavonal 4-0-Alpha-L-
(-)- Rhamnopyranoside 
Root 
4-Methoxy-Norsecurinine Plant 
4-Methoxy – securinine Plant 
5,3’,4’-Trihydroxy flavanone-7-0-Alpha-(-
) Rhamnopyranoside 
Root 
 
Astragalin Plant 
Brevifolin-carboxylic acid Plant 
Cymene Leaf 
Hypophyllanthine Plant 
Limonene Leaf 
Lintetralin Plant 
Lupa-20(29)-ENE-3-β-01 Root 
Lupa -20(29)-ENE-3-Beta-OL-acetate Root 
Lupeol Root 
Methyl-salicylate Plant 
Niranthin Leaf 
Nirtetralin Leaf 
Niruretin Plant 
Nirurin Plant 
Phyllanthin Leaf 
Phyllochrysine Plant 
Phyltetralin Leaf 
Quercetin Plant 
Quercetin-Heteroside Plant 
Quercetol Plant 
Quercitrin Plant 
Rutin Plant 
Saponins Plant 
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Properties  and  medicinal uses 
 The herb is bitter in taste and posses astringent, deobstruent, stomachic, 
diuretic and febrifuge. 
 It is used in stomach disorders like diarrhoea, dysentery, dyspepsia, colic also 
used in dropsy and diseases of urogenital system.  Fresh roots given in jaundice, also 
used as galactagogue. 
 In Rajasthan the roots are used for treating camels suffering from digestive 
troubles.  A decoction of the leaves is used as refrigerant for the scalp.  Leaves and 
roots are made into a poultice with rice water for application on edematous swelling 
and ulcers.  The later is also applied to offensive sores and ulcers and mixed with oil, 
it is used in ophthalmia  
- The wealth of India part VII 
(Pageno-56) 
  Chenca pidera is the spanish name for keezhanelli which means ‘stone 
Breaker’ or shatter stone”.  It is called stone breaker because it is used for dissolve 
gallstones and renal stones and for other kidney problems by the people of amazon. 
 In south america, it is still used for galls stones and renal stones. 
In peru, it is used for hepatitis, urinary infections as a diuretic. 
 In Brazil keezhanelli is called as quebra pedra and is considered as excellent 
medicine to remove uric acid from the urine and to eliminate stones.  It is also used to 
mitigate urinary bladder infections and blockages, liver ailments, joint pain, cystitis 
and diabetes. 
 In India, whole plant used for jaundice, diabetes, diseases of pitha, urinary 
disorders, skin diseases, menorrhagia, vomiting anemia, cough, asthma, bronchitis. 
 
Ethno medicinal uses  
Root - Abortifacient (Tarafder, 1983) 
  Jaundice (Mishra & Sahu, 1984) 
Leaf - Allergy (Bhalla, et.al, 1982) 
Gonorrhoea (Mishra & Sahu, 1984) 
Dysentery (Banerjee, 1977) 
Jaundice (Sharma, et al, 1977) 
Stem -  Dysentery (Mishra & Sahu, 1984) 
Whole plant-  Jaundice (Nagedra prasad & Abraham, 1984) 
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Dropsy & gonorrhoea (Mishra & Sahu, 1984) 
Ulcer, dysentery (Rajwar, 1983) 
Boils (Maheswari, et.al, 1980) 
  The plant also have pharmacological activity like hepato protective activity, 
anti hepatitis B surface antigen.  Anti HIV activity, hypoglycemic activity, 
antispasmodic activity, analgesic activity, antimicrobial activity. 
 A significant hepatoprotective activity is exhibited by the hexane extract of 
dried aerial part at a concentration of 1 mg/ml.  This plant posses potent hepato 
protective effect against toxin induced liver damage. 
 The extract of phyllanthus amarus inhibits endogenous DNA polymerase of 
hepatitis B virus and binds to surface antigen of hepatitis B virus.  Acute and chronic 
infection significantly controlled.  There are indication that an extract may help in 
interrupting HBV carrier state. 
 The extract of phyllanthus amarus is known to inhibit human 
immunodeficiency virus type I reverse transcriptase.  HIV activity inhibitor is 
identified as repadnusinic acid. 
 An aqueous extract of phyllathus amarus is known to produce hypoglycemic 
action in normal as well as allacon-induced diabetes mellitus. 
 Alkaloids from P.amarus exhibits a selective antispasmodic activity on the 
ileum which is equivalent to papaverine.  The antispasmodic activity is due to the 
antagonism of calcium entry into the cell.  This smooth muscle relaxant activity 
within the urinary a billiary tract may facillitate the expulsion of kidney and bladder 
stones. 
 Methanolic extract from callus of plant is known to produce pain relieving  
activity. 
 Water extract of fresh entire plant at a concentration of 1% doesnot exhibit 
any activity against neisseria gonorrhoea.  The saline extract exhibits antibacterial 
activity on pasterulla pestis and staphylococcus aureus.  petroleum ether extract of 
whole plant shows antifungal activity against helminthosporium sativa. 
 The leaf extract is known to exhibit an antifungal effect against alternaria 
alternata. 
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MATERIALS AND METHODS 
Selection of Drug 
 ‘SANGU PARPAM’  as mentioned in the text Gunapadam thathu jeeva 
vaguppu (page number 646) was choosen. 
Ingredients 
 Purified sangu (Turbinella pyrum) 
 Keelanelli juice (Phyllanthus amarus) 
  The sangu was purchased from Fishermen of Tiruchendur Seashore and 
authenticated by Dr. N. Chandrasekar, Rtd. HOD, Department of Geology and Marine 
Technology, Manonmaniam Sundaranar University, Tirunelveli. Keezhanelli plant 
was collected from Palayamkottai, Moolikulam region and authenticated by 
Dr.S.Sudha, HOD, Dept. of Medicinal Botany, Government Siddha Medical College, 
Palayamkottai. 
Method of purification 
 Equal weight of limestone and uvarman was mixed with water.  By leaving the 
sediments, filtrate water are taken.  Sangu (conch shell) was immersed in it.  Then it is 
boiled until water is fully evapourated. Then sangu is washed with water and then 
dried. 
Method of Preparation 
  Purified conch shell (Sangu) is broken into pieces and soaked in juice of 
Keezhanelli for three days. Then it is  put into a mud saucer again Keezhanelli juice is 
added and closed with another mud saucer and sealed with mud cloth and dried. Then 
it is cupellated with fifty cow dung cakes to get parpam. 
Dose 
  ½  (244mg) to 1 panavadai (488mg) twice a day 
Adjuvant: 
  Butter or Lemon juice 
Indication: 
  Maradaippu 
 Nenchu vali 
 Marppu eruchal 
 Neerchurukku 
 Vellai 
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QUALITATIVE AND QUANTITATIVE ANALYSIS 
PHYSICOCHEMICAL ANALYSIS 
 
 Sample Description  : SANGU PARPAM 
 Equipment used  : Atomic Absorption Spectrometer (AAS) 
 
Colour: 
 About 50gm of SANGU PARPAM was taken in a clean glass beaker and 
tested for its colour by viewing again a water opaque background under direct 
sunlight. 
 
pH: 
 The pH of SANGU PARPAM was estimated as per the method prescribed in 
Indian Standard (IS) – 6940 (1982). One gram of the SANGU PARPAM  was taken 
into a 100ml graduated cylinder containing about 50ml of water and filled up to the 
mark with water. The cylinder was stopped and shaken vigorously for two minutes 
and the suspension was allowed to settle for an hour at 250 to 270.  About 25ml of the 
clear aqueous solution was transferred into a 50ml breaker and tested for pH using 
DIGISUN digital pH meter ( DIGISUN Electronics, Hyderabad, India) 
 
Determination of Ash Value: 
 Weighed accurately 2 grams of SANGU PARPAM in tarred platinum or silica 
dish and incinerate at a temperature not be exceeding 4500C until free from carbon, 
cooled and weighed. Calculate the percentage of ash with reference to the air dried 
drug. 
 
Water Soluble Ash: 
 To the gooch crucible containing to the total ash, added 25ml of water and 
boiled for 5 minutes. Collected the insoluble matter in a sintered glass crucible or on 
ash less filter paper. Wash with hot water and ignite in a crucible for 15 minutes at a 
temperature nor exceeding 4500 C  subtract the weight of the insoluble matter from 
the weight of the ash the difference of the weight represents the water soluble ash. 
Calculate the percentage of water soluble ash with reference to the air dried drug. 
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Acid Insoluble Ash: 
 Boiled the ash 5 minutes with 25ml of 1:1 dil HCL. Collect the insoluble 
matter in gooch crucible on an ash less filter paper wash with hot water and ignite. 
Cooled in a desiccators and weighted calculated the percentage of acid insoluble ash 
with reference to the air dried drug. 
 
Loss on Drying: 
 Five grams of SANGU PARPAM is heated in a hot oven at 1050C to constant 
weight and the percentage of loss of weight has calculated there from. 
  FOURIER TR
PERKIN ELMER 
 
FOURIER TRANSFORM 
PERKIN ELMER 
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ANSFORM – INFRA RED SPECTROSCOPY
– SPECFTRUM ONE 
Fig. 3: FTIR Apparatus 
FTIR-Mechanism 
– INFRA RED SPECTROSCOPY
– SPECFTRUM ONE 
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Introduction 
 Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular  structure. The spectral bands can be assigned to different vibrational 
modes of the molecule. The various functional groups present in the molecule can be 
assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular interactions, 
phase transitions and chemical kinetics can be carried out using this branch of 
spectroscopy. 
 In IR spectroscopy, the resonance absorption in made possible by the change 
in dipole moment accompanying the vibrational transition. The infrared spectrum 
originates from the vibrational motion of the molecule. The vibrational frequencies 
are a kind of fingerprint of the compounds. This property is used for characterization 
organic, inorganic and biological compounds. The band intensities are proportional to 
the concentration of the compound and hence qualitative estimations are possible. The 
IR spectroscopy is carried out by using Fourier transform technique. 
Principle 
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction,l electromagnetic radiation characteristic 
of the interacting system may be absorbed (or emitted). The experimental data consist 
of the nature (frequency of wave length) and the amount (intensity) of the 
characteristic radiation absorbed or emitted. These data are correlated with the 
molecurlar and electronic structure of the substance and with intra – and inter 
molecular interactions. 
 FT-IR spectroscopy is used primarily for qualitative and quantitative analysis 
of organic compounds, and also for determining the chemical structure of inorganic 
materials. The region between 500-4000 wave number is referred to as the finger print 
region. Absorption bands in this region are generally due to intra molecular 
phenomena and are highly specific for each material. The specificity if these bands 
allow computerized data searches to be performed against reference libraries to 
identify a material. 
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Table of Characteristic IR Absorptions 
Frequency, cm-1 Bond Functional group 
3640 - 3610 (s, sh) O-H stretch Free hydroxyl alcohols phenols 
3500 - 3200 (s,b) O-H stretch, H – bonded Alcohols, phenols 
3400 – 3250 (m) N – H stretch Primary, secondary, amines, 
amides 
3300 – 2500 (m) O – H stretch Carboxylic acids 
3330 -  3270 (n, s)  –C (triple bond) C – H : C  - H 
stretch 
Alkynes (terminal) 
3100 – 3000 (s) C – H stretch Aromatics 
3100 – 3000 (m) = C – H stretch Alkenes 
3000 – 2850 (m) C – H stretch Alkenes 
2830 – 2695 (m) H – C = 0; C –H stretch  Aldehydes 
2260 -  2210 (v) C (triple bond) N stretch Nitriles 
2260 – 2100 (w) C (triple bond) C- stretch Alkynes 
1760 – 1665 (s) C = 0 stretch Carbonyls (general) 
1760 – 1690 (s) C = 0 stretch Carboxylic acids 
1750-  1735 (s) C = 0 stretch Esters, saturated aliphatic 
1740 – 1720 (s) C = 0 stretch Aldehydes, saturated aliphatic 
1730 – 1715 (a) C = 0 stretch Alpha, beta – unsaturated esters 
1715 (s) C = 0 stretch Ketones, saturated aliphatic 
1710 – 1665 (s) C = 0 stretch Alpha, beta – unsaturat 
aldehydes, ketones 
1680 – 1640 (m) -C = C - Alkenes 
1650 – 1580 (m) N – H bend Primary amines 
1600 – 1585 (m) C-C stretch (in – ring) Aromatics 
1550 – 1475 (s) N – 0 asymmetric stretch Nitro compounds 
1500 – 1400 (m) C –C stretch (in – ring) Aromatics 
1470 – 1450 (m) N – 0 asymmetric stretch Nitro compounds 
1370 – 1350 (m) C – H bend Alkanes 
1360 – 1290 (m) C – H rock Alkanes 
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1335 – 1250 (s) C – N stretch Aromatic amines 
1320 – 1000 (s) C – 0 stretch Alcohols, carboxylic acids, 
esters, ethers 
1300 – 1150 (m) C – H wag ( - CH2X) Alkyl halides 
1250 – 1020 (m) C – N stretch Aliphatic amines  
1000 – 650 (s) =C – H bend Alkynes 
950 – 910 (m) O – H bend Carboxylic acids 
910 – 665 (s, b) N – H wag Primary, secondary amines 
900 – 675 (s) C – H “oop” Aromatics 
850 – 550 (m) C – CI stretch Alkyl halides 
725 – 720 (m) - C (triple bond) C-H : C- H 
bend 
Alkynes 
690 – 515 (m) C  - Br stretch Alkyl halides 
 
M = medium, w = weak, s=strong, n =  narrow, b = broad, sh = sharp 
 
Sampling techniques: 
 There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed. 
 Solid : KBr or Nujol mull method 
 Liquid : CsI / TIBr Cells 
 Gas : Gas Cells 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai – 36KBr Method 
 The Sample was grounded using – an agate mortar and pestle to give a very 
fine powder. 
 The finely powder sample was mixed with about 100 mg dried KBr salt. 
 The mixture was then pressed under hydraulic press using a dye to yield a 
transparent disc (measure about 13 mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed.  
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HR SEM - METHODOLOGY 
 
 
HR SEM-Methodology: 
 An SEM is essentially a high magnification microscope, which used a focused 
scanned collection beam to produce images of the sample, both top-down and, with 
the necessary sample preparation, cross-sections. The primary electron beam interacts 
with the sample in a number of key ways:- 
Primary electrons generate low energy secondary electrons, which tend to emphasize 
the topographic nature of the specimen. 
  Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
  Ionized atoms can relax by electron shell-to-shell transitions. Which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few urn of the sample. 
 
Sample Preparation: 
 Sample preparation can be minimal or elaborate for SEM analysis depending 
on the nature of the samples and the data required. Minimal preparation includes 
acquisition of a SANGU PARPAM that will fit into the SEM chamber. And it should 
be analyzed. 
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES), 
 
 
Fig. 5: ICPOES  Apparatus  
 
ICP OES METHODOLOGY: 
 ICP, abbreviation for Inductively Coupled Plasma, is one method of optical 
emission spectrometry, When plasma energy is given to an analysis sample from 
outside, the component elements (atoms) is excited. When the excited atoms return to 
low energy position, emission rays that correspond to the photon wavelength are 
measured. The element type is determined based on the position of the photon rays, 
and the content of each element is determined based on the ray’s intensity. 
 To generate plasma, first, argon gas is supplied to torch coil, and high 
frequency electric current is applied to the work coil at the tip of the torch tube. Using 
the electromagnetic field created in the torch tube by the high frequency current, 
argon gas in ionized and plasma is generated. This plasma has high electron density 
and temperature (10000K) and this energy is used in the excitation –emission of the 
sample. Solution samples are introduced into the plasma in an atomized state through 
the narrow tube in the center of the torch tube. 
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Sample preparation: 
  Solids cannot be analyzed directly. Such samples should be made into clear 
aqueous medium quantitatively. When acids are used to prepare solutions care should 
be taken. The concentration of the acids in the final provided solution should not be 
more than 2% v/v. highly acidic and organic solutions cannot be analyzed. As a guide 
line weigh exactly, around 200mg of substance and dissolve in 5mL of 5% of water or 
aquaregia or whatever acid to make 100mL of final solution. Make proper dilutions, if 
necessary. Free HF should not present in the final solution to be aspirated. 
  Ideal concentration is around 100 ppm of the element of interest. Total 
dissolved solids should be not more than 0.2% w/v in the final solution Very dilute 
solution may not give reliable results. Each element has a detection limit. A minimum 
solution volume of 25 ml is necessary for analysis. 
In ICP intensity of light emitted when the sample “sprayed or aspirated into an 
argon plasma” is measured at different wavelengths. The intensity of light at a given 
wavelength will be proportional to a particular elemental ion concentration. The 
intensity is calibrated with known standard concentration. For accurate quantitative 
results It is necessary to simulate the sample matrix condition with that of the 
standard. Each element generally will have many emission lines and the sensitivity is 
different for each of this wave length. When more than one element is present it is 
quite common that some emission lines interfere due to overlapping. 
  It is preferable to use plastic containers for sample handling and preserving 
samples for ICP-OES analysis. Glass containers can give problems especially when 
analyzing certain metal ions at low concentration. 
  The samples of  SANGU PARPAM was prepared. 
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ACUTE TOXICITY STUDY IN FEMALE WISTAR ALBINO RATS TO 
EVALUATE TOXICITY PROFILE OF SANGU PARPAM 
 
OBJECTIVES 
 The aim of this study is to evaluate the toxicity of the test substance SANGU 
PARPAM , when administered orally to Female Wistar Albino Rats with different 
doses, so as to provide a rational base for the evaluation of the toxicological risk to 
man and indicate potential target organs. 
 
Guidelines followed: 
 OECD Guidelines No.423 
 The experimental protocol was approved by Institutional Animal Ethical 
Committee as per the guidance of Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and 
Forest, Government of India. 
 
Study design and Controls: 
1) Female Wistar Albino Rats in controlled age and body weight were selected. 
2) SANGU PARPAM  was administered at 5mg/kg, 50mg/kg, 300mg/kg, 2000 
mg/kg body weight as (Water) as suspension along with blank. 
3) The results were recorded on the day of drug administration approximately 1st, 
3rd , 4th and 24th  hour in post dosing and further made into observation upto 14 
days. 
 
EXPERIMENTAL PROCEDURE 
1.Animals 
1.1.Supply 
 A total of 15 Female Wistar Albino Rats with an approximate age of 6 weeks 
are purchased from JAWAHARLAL INSTITUTE OF POSTGRADUATE 
MEDICAL EDUCATION AND RESEARCH, PUDUCHERRY-6. On their arrival, a 
sample of animals was chosen at random and weighted to ensure compliance with the 
age requested. The mean weights of Female Wistar Albino Rats were 100 – 150g 
respectively. The animals were housed in metabolic cages (55 X 32.7 X 19 cm), with 
sawdust litter, in such a way that each cage contained a maximum of 3 rats of the 
same sex. 
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 All animals underwent a period of 14 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this period, 
the animals were inspected by a veterinary surgeon to ensure that they fulfilled the 
health requirements necessary for initiation of the study. 
 
1.2. Housing 
 The Female Wistar Albino Rats were housed in metabolic cages (55 X 32.7 X 
19 cm), placed on racks. From the week before initiation of the treatment, each cage 
contained a maximum of 3 rats of the same sex and treatment group. 
 Each cage was identified by a card, color coded according to the dose level. 
This card stated the cage number, number and sex of the animals it contained, Study 
number, test substance code, administration route, dose level and study drugs name, 
date of the arrival of the animals and initiation of treatment. 
 The temperature and relative humidity were continuously monitored. Lighting 
was controlled to supply 12 hours of light ( 7:00 to 19:00 hours) and 12 hours of dark 
for each 24 hour period. 
  The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22±3°C and the relative humidity was 
maintained between 30 – 70% with 100% exhaust facility. 
 The cages corresponding to each experimental group were distributed on racks 
in such a manner that external factors, such as environmental conditions, were 
balanced as far as possible. 
2.Diet 
 All the rats had free access to a pelleted rat diet. The diet was analyzed by the 
manufacturer to check its composition and to detect possible contaminants. 
2.1. Water 
 The water was offered ad libitum in bottles. 
3.Administration Route and Procedure 
 The test substance was administered orally. The Female Wistar Albino Rats 
belonging to the control group were treated with the vehicle(Water) at the same 
administration volume as the rest of the treatment groups. 
The animals were marked on body with picric acid solution prepared in water.  
The marking within the cage was as below. 
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Table-1 Grouping and Marking of Animals 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
The group number, cage number, sex of the animal and animal number were 
identified as indicated below using cage label and body marking on the animals. 
Table – 2 Numbering and Identification 
Cage No Group No Animal marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
 
3.1. Doses: 
 The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighted and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
Table – 3. Doses 
GROUP DOSE 
Group –I Control 
Group – II 5mg/kg 
Group – III 50mg/kg 
Group – IV 300mg/kg 
Group – V 2000mg/kg 
 
 The test substance was administered as single dose. After single dose 
administration period, all animals were observed for 14 days. 
 
3.2. Dose Preparation 
 SANGU PARPAM was added in distilled water and completely dissolved to 
oral form for administration. The dose was prepared for a required concentration 
46 
 
before dosing by dissolving in distilled water. It was mixed well. The preparation for 
different doses was vary in concentrations to allow a constant dosage volume. 
 
3.3. Administration 
 The test substance was administered orally to each female Wistar Albino rats 
as single dose using a needle [straight, 10guage, 5.9 inches (15.2cm) length, 6.4mm 
tip] fitted onto a disposable syringe of appropriate size at the following different 
doses. The concentration was adjusted according to its body weight. The volume was 
not exceeding 10ml/kg bodyweight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
3.4. Observation period 
 All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, 
were recorded for approximately 1.0, 3.0, 4.0 and 24.0 hours post-dose on day of 
dosing and once daily thereafter for 14 days. Animals in pain or showing severe signs 
of distress were humanely killed. The cageside observation includes changes in skin, 
fur, eyes and mucous membranes, occurrence of secretions and excretions. 
Autonomic activity like lacrimation, piloerection, pupil size and unusual respiratory 
pattern, changes in gait, posture, response to handling, presence of clonic or tonic 
movements, stereotypes like excessive grooming and repetitive circling or bizarre 
behavior like self – mutilation, walking backwards etc were observed. At the 14th day, 
sensory reactivity to stimuli of different types (e.g: auditory, visual and proprioceptive 
stimuli) was conducted. Auditory stimuli responses were measured by clicker sound 
from approximately 30cm to the rats; Visual stimuli response were measured with the 
help of shining pen light in the eye of rats and placing a blunt object near to the eye of 
rats. Response to proprioceptive stimuli was measured by placing anterior/dorsal 
surface of animals paw to the table edge. The responses of reactions for these three 
exercises were normal in animals belonging to both the controls as well as drug 
treatment dose groups. 
 
4.0 Mortality and Morbidity 
 All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0, 4.0 and 24.0 hours post dose on day of dosing and twice daily 
(morning and afternoon) thereafter for 14 days. 
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SUB-ACUTE TOXICITY STUDY IN WISTAR ALBINO RATS TO 
EVALUATE TOXICITY PROFILE OF SANGU PARPAM  
1.Objective 
 The objective of this ‘Sub-acute toxicity study of SANGU PARPAM on 
Wistar Albino Rats’ was to assess the toxicological profile of the test item when 
treated as a single dose. Animals should be observed for 28 days of drug 
administration. This study provides information on the possible health hazards likely 
to arise from exposure over a relatively limited period of time. 
 
2. Test Guideline followed 
 OECD 407 Method – Sub-Acute Toxic Class Method (Repeated Dose 28-Day 
Oral Toxicity Study in Rodents) 
 
3. Test Substance Detail 
 Name : SANGU PARPAM  
 
4. Test System Detail 
 The study was conducted on 3 male and 3 female Wistar Albino Rats. These 
animals were selected because of the recommended rodent species for oral studies as 
per followed guideline and availability of animals 6 weeks old male and female rats 
were selected after physical and behavioral examination. The body weight range was 
fallen within ± 20% of the mean body weight at the time of randomization and 
grouping. The rats were housed in standard laboratory condition in Polypropylene 
cages, provided with food and water ad libitum. The experimental protocol was 
approved by Institutional Animal Ethical Committee as per the guidance of 
Committee for the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Environment and Forest, Government of India. 
 
 
5.Acclimatization 
 The animals were selected after veterinary examination by the Veterinarian. 
All the selected animals were kept under acclimatization for a week. 
 
6.Randomization & grouping 
 One day before the initiation of treatment (days 0- last day of acclimatization), 
the selected animals were randomly grouped into four different groups containing 
minimum   6 animals (3 Male + 3 Female) per group. 
48 
 
7. Numbering and Identification 
 The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
Table-4  Animal Identification 
Group No Animal marking 
Control H,B,T, E, L, NM 
Low dose  H,B,T, E, L, NM 
Mid dose  H,B,T, E, L, NM 
High dose  H,B,T, E, L, NM 
 
 The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals. 
 
Table-5  Animal Marking 
Cage no Group no Animal marking Sex 
1 Control 
H, B,T Male 
E, L, NM Female 
2 Low dose 
H, B,T Male 
E, L, NM Female 
3 Mid dose 
H, B,T Male 
E, L, NM Female 
4 High dose 
H, B,T Male 
E, L, NM Female 
H – Head,  B – Body,  T – Tail, E- Earlobe, L – Limb,  NM – No Marking 
 
8. Husbandry 
8.1. Housing 
 The Wistar Albino Rats were housed in standard polypropylene cages with 
stainless steel top grill. Paddy husk was used as bedding. The paddy husk was 
changed at least twice in a week. From the week before initiation of the treatment, 
each cage contained a maximum of 3 rats of the same sex and treatment group. 
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8.2. Environmental conditions 
 The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22±3°C and the relative humidity was 
maintained between 30 – 70% with 100% exhaust facility. The cages corresponding 
to each experimental group were distributed on racks in such a manner that external 
factors such as environmental conditions were balanced as far as possible. 
 
8.3 Feed & feeding schedule 
 Feed was provided ad libitum throughout the study period, except over night 
fasting (18-20 hours) prior to dose administration. After the substance has been 
administered, food was with held for a further 3-4 hours. 
 
8.4 Water 
 The water was offered ad libitum in bottles. They were periodically analyzed 
to detect the presence of possible contaminants. 
 
8.5 Doses 
 The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then test 
substance was administered orally as single dose using a needle fitted onto a 
disposable syringe of approximate size at the following different doses. 
 
Table – 6 Dose level 
TEST GROUP 
DOSE TO ANIMALS (mg/kg 
body – weight/day) 
NUMBER OF 
ANIMALS 
Group – I Control 6(3male and 3female) 
Group – II 
Low dose of SANGU PARPAM                         
(200mg/ Kg) 
6(3male and 3female) 
Group – III 
Mid dose of SANGU PARPAM 
(400mg/ Kg) 
6(3male and 3female) 
Group – IV 
High dose of SANGU PARPAM 
(600mg/ Kg) 
6(3male and 3female) 
 
 The test substance was administered as single dose for 28 days and all animals 
are observed . 
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8.5 a. Dose preparation 
 SANGU PARPAM was added in distilled water and completely dissolved to 
for oral for administration. The dose was prepared of a required concentration before 
dosing by dissolving SANGU PARPAM in distilled water. It was mixed well. The 
preparation for different doses was vary in concentrations to allow a constant dosage 
volume. 
 
8.6. Administration 
 The test substance was administered orally to each rat as single dose using a 
needle fitted onto a disposable syringe of appropriate size at the following different 
doses. The concentration was adjusted according to its body weight. The volume was 
not exceeding 10ml/kg body weight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
9. Observation 
 These observations were also performed on week – ends. The observations 
included but were not limited to changes in skin, fur, eyes, mucous membranes, and in 
the respiratory, circulatory, central nervous, autonomous systems, somatomotor 
activity and behavior. 
 
9.1. Clinical signs of toxicity 
 All the rats were observed atleast twice daily with the purpose of recording 
any symptoms of ill-health, behavioral changes and clinical signs of toxicity daily for 
28 days. 
 
9.2. Food intake 
 Prior to the beginning of treatment and daily food intake of each cage was 
recorded for period of 28 days and the mean weekly intake per rats was calculated. 
 
9.3 Water intake 
 Water intake was checked by visual observation during the study. In addition, 
the water consumption in each cage was measured daily for a period of 28days. 
 
9.4 Body weight 
 The body weight of each rat was recorded one week before the start of 
treatment, and during the course of the treatment on the day of initial, 7th, 14th , 21st  
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and 28th day. The mean weight for the different groups and sexes were calculated 
from the individual weight. 
 
Blood collection 
 Blood was collected through retro – orbital sinus from all the animals of 
different groups on 29th day. The blood was collected in tubes containing 
Heparin/EDTA as an anticoagulant. Animals were fasted over night prior to the blood 
collection. 
 
LABORATORY STUDIES 
 After the 4th week of treatment, samples of blood were withdrawn from the 
orbital sinus from each group, under weak ether anesthesia after fasting for 16 hours. 
The blood samples are used to evaluate Hematological parameters like RBC, WBC, 
Hb% and DC. The collected blood samples also centrifuged 10000rpm in 10 minutes 
to separate the serum. The separated serum used to evaluate biochemical parameters 
like SGOT, SGPT, ALP, UREA and CREATININE etc. 
 
Hematology 
 The following hematological parameters were analysed using Autoanalyser 
  Hb  : Haemoglobin(gm%) 
  WBC  : White Blood Corpuscles (x103/cu.mm) 
  RBC  : Red Blood Corpuscles (x106/cu.mm) 
 Differential count: 
  N  : Neutrophils (%) 
  L  : Lymphocytes (%) 
  M  : Monocytes (%) 
  E  : Eosinophils (%) 
  B  : Basophils (%) 
Clinical biochemistry: 
 The following clinical Bio-chemical parameters were analysed using Auto 
analyser 
  ALT/SGPT  : Alanine amino transferase (U/L) 
  AST/SGOT  : Aspartate amino transferase (U/L) 
  ALP   : Alkaline serum phosphatase (U/L) 
  SERUM UREA (mg/dl) 
  SERUM CREATININE ( mg/dl) 
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Terminal studies 
Sacrifice and macroscopic examination 
 On completion of the 28 days of treatment,  Wistar Albino Rats were 
sacrificed by ether inhalation. A full autopsy was performed on all animals which 
included examination of the external surface of the body, all orifices, cranial, thoracic 
and abdominal cavities and their contents both in situ and after evisceration. As the 
number of animals exceeded the number that could be sacrificed in one day, the 
autopsies were carried out over three consecutive days at the end of the treatment 
period. 
Organ weights: 
 After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Heart, Kidneys and Liver. 
 
HISTOPATHOLOGICAL STUDIES 
 Anatomy of the liver was studied immediately after sacrificing the animals. A 
small portion was fixed in 10% neutral buffered formalin as described by Luna 14. 
Thin sections of 4-5µm were taken, stained with Haematoxylin and Eosin and 
histology was studied. 
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RESULTS 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
Table -7 
Colour characters of SANGU PARPAM 
No Nature of drug Nature of colour 
1 SANGU PARPAM Light Yellow 
 
Table 8— Physicochemical analysis of samples of SANGU PARPAM  
[Values are mean of three determinations ±SEM] 
Parameters Total ash Values 
Ash value 
Water soluble ash 
Acid insoluble ash 
7.75±0.011 
0.95±0.011 
Extractive value Water soluble extractive value 8.20±0.310 
Loss on drying Loss on drying at 70°C 7.30±0.240 
 
SEM- singularity expansion method 
Table-9 
Particle size and pH of SANGU PARPAM 
S.No Parameters Values obtained 
1 Particle size by SEM 0.5-2 µ 
2 pH 9.540 
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SANGU PARPAM (FTIR METHOD) 
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Table - 10 
SANGU PARPAM 
Table of characteristic IR Absorptions 
Absorption cm-1 Intensity Class of 
compounds 
Assignment 
699 S Aromatic 
compound 
C-H bond 
 S,  broad Alkynes =C-H bend 
 M-S,  broad Alkene =C-H bend 
712 M-S, broad Alkene =C-H bend 
782 S Alkyl halide C-Cl stretch 
 S Aromatic 
compound 
C-H bend 
861    
1082 VS Alkyl halide C-F stretch 
 M-S Alcohol C-O stretch 
1479 M-S Aromatic 
compounds 
ring C=C stretch 
1786 S Acyl chloride C=O stretch 
 S Esters C=O stretch 
2521 S, broad Carboxylic acid O-H stretch 
2924 S, broad Carboxylic acid O-H stretch 
3430 W-M Amides N-H sym S 
asym.stretch 
 S, broad Carboxylic acid O-H stretch 
 W Amine N-H stretch 
 
Inference :  
  The SANGU PARPAM contains, Aromatic compounds, Alkynes, Alkene, 
Alkyl halide, Alcohal, Acyl chloride, Esters, Carboxylic acids, Amides, Amines. 
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SEM ANALYSIS 
Scanning Electron Microscope (SEM) 
 
SEM -5000 Magnification 
 
 
SEM -10000 Magnification 
 
Results and Interpretation of SEM analysis: 
   The morphology of the SANGU PARPAM sample can be determined by 
SEM (FEI Quanta). A representative portion of each sample must be  sprinkled onto a 
double side carbon tape and mounted on aluminium stubs, in order to get a higher 
quality secondary electron image for SEM examination. We have observed from SEM 
photographs that particles are spherical in shapes and sizes are in the range from    
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0.5-2 micron.   Although the particle sizes of different batches showed similarity, it 
seems that these particles are aggregates of much smaller particles. When dispersed in 
an aqueous medium, these preparations form a negatively charged hydrophobic 
particle suspension. This hydrophobicity gives these particles a tendency to aggregate 
together to form larger particles. Sangu parpam exhibited larger sizes and 
agglomeration of the particles. Therefore, the comparatively larger size may be due to 
the agglomeration of the particles by repeated cycles of calcinations involved in 
preparation. 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM, CHENNAI-36 
PERKIN ELMER OPTIMA 5300 DV ICP-OES 
  
Sample ID                                  Elements Symbol                   Concentration 
                                                    Wavelength (nm)  
(wt:0.31120g)  
 
Al 396.152                  BDL 
As 188.979 BDL 
Ca 315.807 422.180 mg/L 
Cd 228.802  BDL 
Cu 327.393 BDL 
Fe 238.204 00.376 mg/L 
Hg 253.652 BDL 
K 766.491 00.821 mg/L 
Mg 285.213 01.124 mg/L 
Na 589.592 01.320 mg/L 
Ni 231.604 BDL 
Pb 220.353 BDL 
P 213.617 76.341 mg/L 
S 180.731 01.314 mg/L 
Zn 206.200 01.228 mg/L 
 
 
BDL- Below detection limit 
 
SANGU PARPAM contains Aluminium, Arsenic, Cadmium, Copper, Mercury, 
Nickel, Lead are in below detection limit. 
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RESULTS: 
 
PH range :  9.54 
FTIR data :  SANGU PARPAM contains  Aromatic compounds, Alkynes,  
Alkene,  Alkyl halide, Alcohal, Acyl chloride, Esters, 
Carboxylic acids, amides and amines. 
HR SEM    :  SANGU PARPAM has the particle size in the range of   
0.5 - 2 micron  
ICP-OES data :  SANGU PARPAM shows Aluminium, Arsenic, Cadmium,  
Copper, Mercury, Nickel and Lead are in below detection limit. 
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BIO-CHEMICAL ANALYSIS OF SANGU PARPAM 
Preparation of the extract:   
  100mgs of parpam is weighted accurately and placed into a clean beaker and 
added a few drops of Conc.  Hydrochloric acid and evaporated it well. After 
evaporation cooled the content and added a few drops of conc. nitric acid and 
evaporated it well. After cooling the content  add 20ml of distilled water and 
dissolved it well. Then it is transferred to 100ml volumetric flask and made up to 
100ml with distilled water, mix well, filter it. Then it is taken for analysis. 
Table - 11 
BIO-CHEMICAL ANALYSIS  
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  
TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution 
A white precipitate is 
formed 
Indicates the 
presence of 
calcium 
2. 
TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
A white precipitate is 
formed 
Indicates the 
presence of 
sulphate 
3.  
TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution 
A white precipitate is 
formed 
Indicates the 
presence of 
chloride 
4. 
TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
A Brisk 
effervessence is 
formed 
Indicates the 
presence of 
carbonate 
5. 
 
TEST FOR STARCH 
The extract is added with weak iodine 
solution 
No Blue colour is 
formed 
Absence of 
starch 
6.  
TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro cyanide. 
 
No blue colour is 
formed 
Absence of ferric 
iron 
  
61 
 
7. 
TEST OF FERROUS IRON  
The extract is treated with concentrated 
Nitric acid and Ammonium thio cyanate 
solution 
Blood red colour is 
formed 
Indicates the 
presence of 
ferrous iron 
8.  
TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow 
precipitate is formed 
Absence of 
phosphate 
9.  
TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is formed 
Absence of 
Albumin 
10.  
TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
No Blue black 
precipitate is formed 
Absence tannic 
acid 
11.  
TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It doesnot  gets 
decolourised. 
 
Absence of 
unsaturated 
compound 
12.  
TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 mts and add 8-10 drops of the extract 
and again boil it for 2 mts. 
No colour change 
occurs. 
Absence of 
Reducing sugar 
13.  
TEST FOR AMINO ACID 
One or two drops of the extract is placed 
on a filter paper and dried well. After 
drying, 1% Ninnhydrin is sprayed over 
the same and dried it well. 
No Violet colour is 
formed 
Absence of 
Amino acid 
14. 
TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white precipitate 
is formed 
Absence of Zinc. 
 
Inference: 
  Analysis reveals the presence of Calcium, Sulphate, Chloride, Carbonate, 
Ferrous iron in SANGU PARPAM . 
  Biochemical Analyis report was given by Mrs. N.Nagaprema, M.Sc., H.O.D, 
Bio Chemical Department, Government Siddha Medical College, Palayamkottai. 
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Effect of Acute Toxicity (14 Days) of SANGU PARPAM  
Table - 12 Physical and behavioral examinations. 
Group no. Dose(mg/kg) Observation sign No. of animal 
affected. 
Group-I Control Distilled 
water (1ml/kg) 
Normal 0 of 3 
Group- II 5mg/kg Normal 0 of 3 
Group-III 50mg/kg Normal 0 of 3 
Group-IV 300mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
 
Table- 13 Showed the effect of  Control – Distilled water (1ml/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior 
Time of observation after Control - Distilled 
water (1ml/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
‘+’ PRESENT & ‘-‘ ABSENT 
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Table - 14 Showed the effect of SANGU PARPAM  (5mg/kg) on general behavior 
after single oral administration in Rat. 
SI.NO General Behavior Time of observation after SANGU PARPAM  
(5mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table - 15 Showed the effect of SANGU PARPAM  (50mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after SANGU PARPAM  
(50mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table - 16 Showed the effect of SANGU PARPAM  (300mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after SANGU PARPAM  
(300mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table  - 17  Showed the effect of SANGU PARPAM  (2000mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after SANGU PARPAM  
(2000mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table - 18 Home cage activity 
Functional and 
Behavioral 
observation 
Observation 
Control 
Distilled 
water 
(1ml/kg) 
5mg/kg 
Group 
(G-II) 
50mg/kg 
(G-III) 
300mg/kg 
(G-IV) 
 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Approach 
response 
Normal 3 3 3 3 3 
Touch response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tailpinch response Normal 3 3 3 3 3 
 
Table  - 19  Hand held observation 
Functional and 
Behavioral observation 
O
bs
er
v
a
tio
n
 Control 
Distilled 
water 
(1ml/kg) 
5 
mg/ kg 
(G-II) 
50 
mg/kg 
(G-II) 
300 
mg/kg 
(G-III) 
2000 
mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 
Handling Normal 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 
Pupillary reflex Normal 3 3 3 3 3 
Abdominal tone Normal 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 
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Table - 20 Mortality 
Group no Dose  level (mg/kg) Mortality 
Group-I 
Control 
[Distilled water (1ml/kg)] 
0 of 3 
Group-II 5(mg/kg) 0 of 3 
Group-III 50(mg/kg) 0 of 3 
Group-IV 300(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
Result: 
 From acute toxicity study it was observed that the administration of SANGU 
PARPAM up to the dose of 2000mg/kg to the rats do not produce drug-related 
toxicity and mortality. So No-Observed-Adverse-Effect-Level(NOAEL) of SANGU 
PARPAM is 2000mg/kg. 
 
DISCUSSION 
 SANGU PARPAM was administered single time at the dose of 5mg/kg, 
50mg/kg, 300mg/kg and 2000mg/kg to rats and observed for consecutive 14 days 
after administration. Doses were selected based on the pilot study and literature 
review. All animals were observed daily once for any abnormal clinical signs. Weekly 
body weight and food consumption were recorded. No mortality was observed during 
the entire period of the study. Data obtained in this study indicated no significance 
physical and behavioral signs of any toxicity due to administration of SANGU 
PARPAM at the doses of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rat. 
 At the 14th day, all animals were observed for functional and general 
behavioral examination. In functional and general behavioral examination, home cage 
activity, hand held activity were observed. Home cage activities like Body position, 
Respiration, Clonic involuntary movement, Tonic involuntary movement, Palpebral 
closure, Approach response, Touch response, Pinna reflex, Sound responses, Tail 
pinch response were observed. Handheld activities like reactivity, Handling, Palpebral 
closure, Lacrimation, Salivation, Piloerection, Papillary reflex, abdominal tone, Limb 
tone were observed. Functional and general behavioral examination was normal in all 
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treated groups. Food consumption of all treated animals was found normal as 
compared to normal group. 
 Body weight at weekly interval was measured to find out effect of SANGU 
PARPAM on the growth rate. Body weight change in drug treated animals was found 
normal. 
 
SUMMARY & CONCLUSION 
Summary: 
 The present study was conducted to know single dose toxicity of SANGU 
PARPAM on female Wistar Albino Rats. The study was conducted using 15 female 
Wistar Albino Rats. The female animals were selected for study of 8-12 weeks old 
with weight range of within ±20% of mean body weight at the time of randomization. 
The groups were numbered as group I, II, III, IV and V and dose with 5mg/kg, 
50mg/kg, 300mg/kg and 2000mg/kg of SANGU PARPAM. The drug was 
administered by oral route single time and observed for 14 days. Daily the animals 
were observed for clinical signs and mortality. Body weight of animals was recorded 
once in a week. 
 There were no physical and general behavioral changes observed in Wistar 
Albino Rats of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rats during 14 days. 
 Body weight of all animals did not reveal any significant change as compared 
to vehicle control group. 
 Food consumption of all group animals was normal. 
 Mortality was not observed in all treatment groups. 
Conclusion: 
 The study shows that SANGU PARPAM did not produce any toxic effect and 
mortality at dose of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rats. So NO-
Observed-Adverse-Effect-Level(NOAEL) of SANGU PARPAM is 2000mg/kg. 
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SUB-ACUTE TOXICITY RESULTS 
 
Table - 21. RESULTS OF SUB-ACUTE TOXICITY STUDY (28 DAYS) OF  
SANGU PARPAM   ON BODY WEIGHT (IN GRAM)                                     
(PHYSICAL PARAMETER) 
GROUP CONTROL LOW MID HIGH 
1st day 122.3±1.05 125±1.543 124.3±2.1 123.3±1.03 
7th day 132.3±1.03 131.3±1.342 130±2.012 134.3±1.03 
14th day 134±1.004 134.3±1.12 134±1.13 134.1±1.004 
21st day 138±1.20 139±1.50 140±2.23 138±2.12 
28th day 140±1.04 141±2.23 143±2.04 141.3±1.04 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by Dunnett’s (n=6); NS- non significant, *p<0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group. 
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Table - 22 RESULTS OF SUB-ACUTE TOXICITY STUDY (28 DAYS) OF 
SANGU PARPAM   ON FOOD INTAKE IN grams. 
 
GROUP CONTROL LOW MID HIGH 
1st day 40.16±3.3 39±2.09 40±3.8 40.5±2.54 
7th day 41.8±2.54 40.7±1.91 41±2.42 40.8±2.5 
14th day 42.6±1.52 41.52±2.3 42.53±2.57 42.55±1.8 
21st day 43.57±2.35 42.65±1.6 43.55±2.22 44.58±3.5 
28th day 45.62±2.19 44.32±1.12 45.68±3.10 46.21±1.6 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s (n=6); NS- non significant, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group. 
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Table - 23 RESULTS OF SUB-ACUTE TOXICITY STUDY (28 DAYS) OF 
SANGU PARPAM   ON WATER INTAKE IN (grams). 
 
GROUP CONTROL LOW MID HIGH 
1st day 93±15.6 94.5±12 95±15.6 94±14.4 
7th day 92.3±11 92±15.12 93±15.6 91.8±12.6 
14th day 94±14.4 94±14.4 94±16.3 93±10.54 
21st day 92±14 92±17.1 93±15.6 96.8±6.6 
28th day 93.1±15.6 94±14.4 96±11.2 98±11.4 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by Dunnett’s (n=6); NS- non significant, *p<0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group. 
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Table – 24  RESULTS OF SUB-ACUTE TOXICITY STUDY (28 DAYS) OF 
SANGU PARPAM ON ORGAN WEIGHT IN (grams). 
 
GROUP CONTROL LOW MID HIGH 
HEART 0.87±0.02 0.84±0.01 0.86±0.11 0.87±0.11 
LIVER 6.32±0.23 6.43±0.23 6.30±0.02 6.47±0.02 
KIDNEY L 0.93±0.02 0.92±0.03 0.93±0.02 0.95±0.02 
 R 0.91±0.02 0.93±0.02 0.91±0.01 0.92±0.03 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by Dunnett’s (n=6); NS- non significant, *p<0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group. 
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Table - 25 Shows the effect SANGU PARPAM on Hematological parameters in 
rats after 28 days treatment 
Drug 
treat
ment 
RBC 
million 
cells/cu
.mm 
WBC  
cells/cu
.mm 
Haemog
lobin 
gm % 
Differential count % 
Neutro
phils 
Eosino
phils 
Mono
cyte 
Baso
phil 
Lymph
ocyte 
Contr
ol 
4.21±0.
1 
9253.5
1± 
41.32 
12.10 ± 
0.6 
 
31.72± 
1.60 
 
1.93 ± 
0.15 
 
3.89 ± 
0.19 
0 
 
63.17 ± 
3.76 
LOW 
4.14±0.
20 
9554.0
5 ± 
33.32 
12.30 ± 
0.83 
 
34.61 ± 
2.06 
 
1.92 ± 
0.09 
 
3.09± 
0.11 
0 
 
60.09 
±2.55 
MID 
4.33±0.
21 
9553.3
6 ± 
74.46 
12.22 ± 
1.03 
 
32.36± 
1.11 
 
1.87 ± 
0.02 
 
3.44± 
0.10 
0 
 
64.42 
±3.04 
HIGH 
4.21±0.
10 
9255.5
1 ± 
41.32 
12.10 ± 
0.69 
32.16 ± 
1.3 
1.97 ± 
0.05 
3.57 ± 
0.25 
0 
62.3 ± 
2.76 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by Dunnett’s (n=6); NS- non significant, *p<0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group. 
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Table  - 26  RESULTS OF SUB- ACUTE TOXICITY STUDY (28 DAYS) OF 
SANGU PARPAM  ON BIOCHEMICAL PARAMETERS 
 
Drug 
Treatment 
SGPT 
(IU/L) SGOT(IU/L) ALP(IU/L) 
Urea 
(mg/dl) Creatinine(mg/dl) 
Control 27.11±3.03 87.25±1.71 54.22±11.43 16.49±3.0 0.61±0.03 
LOW 28.24±3.323 89.24±1.01 62.21±12.1 19.64±2.82 0.60±0.01 
MID 28.32±1.11 91.31±2.62 66.56±5.51 18.22±2.22 0.56±0.01 
HIGH 27.71±3.30 94.31±1.72 69.22±11.43 18.49±3.00 0.66±0.03 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by Dunnett’s (n=6); NS- non significant, *p<0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group. 
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HISTOPATHOLOGICAL OBSERVATIONS 
EFFECT OF SANGU PARPAM ON HISTOPATHOLOGICAL CHANGES IN RAT 
ORGANS 
 
 
 
Group –I – Control 
Name                 : K.BALA SUBRAMANIAN – RAT-NORMAL                                
Ref by Dr. :                 Sample Received Date:  08.05.2018    
Specimen :  HEART – NORMAL       Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 736  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal cardiac muscle fibres seen.   
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Name                 : K.BALA SUBRAMANIAN – RAT- NORMAL                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  LIVER - NORMAL          Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 732  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal liver parenchyma seen.   
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Name                 : K.BALA SUBRAMANIAN – RAT-NORMAL                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  KIDNEY - NORMAL      Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 744  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal renal parenchyma seen.  
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Group – II Low dose 200mg/kg/Animal 
 
Name                 : K.BALA SUBRAMANIAN – RAT-LOW DOSE                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  HEART – G1     Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 737  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal cardiac muscle fibres seen.  
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Name                 : K.BALA SUBRAMANIAN – RAT- LOW DOSE                                
Ref by Dr. :                   Sample Received Date:  08.05.2018    
Specimen :  LIVER – G1                       Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 733  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal liver parenchyma seen.   
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Name                 : K.BALA SUBRAMANIAN – RAT-LOW DOSE                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  KIDNEY – G1                  Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 745  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal renal parenchyma seen.  
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Group – III Mid dose 400mg/kg/Animal 
 
Name                 : K.BALA SUBRAMANIAN – RAT-MIDDLE DOSE                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  HEART – G2                   Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 738  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal cardiac muscle fibres seen.  
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Name                 : K.BALA SUBRAMANIAN – RAT- MIDDLE DOSE                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  LIVER – G2                     Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 734  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal liver parenchyma seen.   
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Name                 : K.BALA SUBRAMANIAN – RAT-MIDDLE DOSE                                
Ref by Dr. :   Sample Received Date:  08.05.2018    
Specimen :  KIDNEY – G2                  Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 746 / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal renal parenchyma seen.  
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Group – IV High dose 600mg/kg/Animal 
Name                 : K.BALA SUBRAMANIAN – RAT-HIGH DOSE                                
Ref by Dr. :  Sample Received Date:  08.05.2018    
Specimen :  HEART – G3    Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 739  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal cardiac muscle fibres seen.  
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Name                 : K.BALA SUBRAMANIAN – RAT-HIGH DOSE                                
Ref by Dr. :    Sample Received Date:  08.05.2018    
Specimen :  LIVER – G3                     Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 735  / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal liver parenchyma seen.   
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Name                 : K.BALA SUBRAMANIAN – RAT-HIGH DOSE                                
Ref by Dr. :  Sample Received Date:  08.05.2018    
Specimen :  KIDNEY – G3  Sample Reported Date:  20.05.2018 
   
                                                                                            BIOPSY NO : 747 / 2018 
Clinical Details: 
  
 
Clinical Diagnosis :  
Macroscopic :  
 
 
Microscopic: 
Normal renal parenchyma seen.  
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6.0 RESULTS: 
 CLINICAL SIGNS: 
All animals in this study were free of toxic signs throughout the dosing period 
of 28 days.  
 
Mortality: 
All animals in control and in all the treated dose groups survived throughout 
the dosing period of 28 days. 
 
 Body weight: 
The effect of SANGU PARPAM on body weight during 28 days treatment in 
rats was given in table 21. There was no significant change in the body weight 
compared to control with both the doses of SANGU PARPAM during 28 days 
treatment. 
 
Food consumption: 
  The effect of SANGU PARPAM on food intake during 28 days treatment in 
rats was given in table 22. SANGU PARPAM did not alter the food intake at both the 
dose levels as compared to control during the 28 days treatment. It indicates that it 
does not influence food intake. 
 
Water consumption: 
The effect of SANGU PARPAM on water intake during 28 days treatment in 
rats was given in table 23. SANGU PARPAM did not alter the water intake at both 
the dose levels as compared to control during the 28 days treatment. There was no 
significant change in water intake as compared to control. 
 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in                  
Table No.24 Comparison of organ weights of treated animals with respective control 
animals on day 28 was found to be comparable similarly. 
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Hematological investigations: 
The results of hematological investigation (Table.25) conducted on 28th day  
revealed following significant changes in the values of different parameters 
investigated when compared with those of respective controls; however, the increase 
or decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
 
Biochemical Investigations: 
Results of Biochemical investigations conducted on 28th  day and recorded in 
revealed the following significant changes in the values of hepatic serum enzymes 
studied. When compared with those of respective control. However, the increase or 
decrease in the values obtained was within normal biological and laboratory limits. 
 
Histopathology: 
In histopathological examination, revealed normal architecture in comparison 
with control and treated animal. 
 
7.0 DISCUSSION: 
1)  All the animals from control and all the treated dose groups up to 600 mg/kg 
survived throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during 
the dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 28, 
revealed no abnormalities attributable to the treatment. 
6) Organ weight data of animals sacrificed at the end of the dosing period was found 
to be comparable with that of respective controls. 
7) Histopathological examination revealed normal architecture in comparison with 
control and treated animal. 
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8.0 SUMMARY AND CONCLUSION:  
In conclusion SANGU PARPAM  can be considered safe, as it did not cause 
either any lethality or adverse changes with general behavior of rats and also there 
were no observable detrimental effects (200 to 600 mg/kg body weight) over a 
period of 28 days. Our results have demonstrated that the SANGU PARPAM  is to be 
relatively safe when administered orally in human for long period. 
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BIOSTATISTICAL ASPECTS 
 Biological assay refers to assessment of the potency of vitamins, hormones, 
toxicants and drugs of  all types by means of the responses produced when  doses are 
given to experimental animals. In every dose response situation, two components 
must be considered; the Stimulus and the Subject. 
 The stimulus is applied to the Subject as a stated dose namely concentration, 
weight, time or appropriate measure. The subject manifest a response, the level of 
intensity below which the response does not occur & above which the response occur, 
such a value has often been called threshold. But the term tolerance is now widely 
accepted.  
 
MEDIAN EFFECTIVE DOSE (ED50) 
 It is the dose which produces the desired response in half the animal 
population tested. 
 
MEDIAN LETHAL DOSE (LD 50) 
 It is the dose which kills half the population of the animal tested.  
 
LD50 Measurment( Toxicity) 
• If the test compound shows any pharmacological activity then the 
LD50 of the drug is determined. 
• By determining the LD50, we can justify whether to proceed with the 
drug or not. 
Table  - 27 
Acute Toxicity Study Analysis 
Group Dose in mg / kg No. of rats No. of  rats died 
I 
Distilled water 
(1ml/kg) 
3 - 
II 5 3 - 
III 50 3 - 
IV 300 3 - 
V 2000 3 - 
 
 Since there was no mortality of the animal in acute toxicity study, lethal dose 
of drug could not be calculated.  
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Table  - 28 
Subacute Toxicity Study Analysis 
Group Dose (mgs / kg) No. of rats 
 
Days 
 
No. of rats 
died 
I Control 6 (3 M + 3F) 28 - 
II 200 6 (3 M + 3F) 28 - 
III 400 6 (3 M + 3F) 28 - 
IV 600 6 (3 M + 3F) 28 - 
  
  In case of Subacute Toxicity Study, with the help of physiological parameters 
such as Hematological investigations and with the histopathological studies the drug 
reaction within the animal can be assessed and are being tabulated respectively. 
 Lethal dose of the drug “SANGU PARPAM ” can be calculated with higher 
dose level of the drug which can be done in further studies. 
  From the above biostatistical measures “SANGU PARPAM”  is safe upto the 
dose level 600mg/kg body weight of the animal. 
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 DISCUSSION 
 
 The present study with SANGU PARPAM  was conducted with an objective 
to find out whether this drug has got any side effects or adverse reactions in 
short and Long term administration 
 ICP OES analysis indicates that Aluminium, Arsenic, Cadmium, Copper, 
Mercury,  Nickel and  Lead are  in below detection Limit. 
 FTIR analysis of SANGU PARPAM  indicates the presence of Aromatic 
compounds, Alkynes, Alkene, Alkyl halide, Alcohol, Acyl chloride, Esters, 
Carboxylic acids, Amides and Amines. 
 SEM analysis indicated that the particle size were in Range 0.5-2 micron. 
 Biochemical Analysis of SANGU PARPAM  indicates the presence of 
Calcium, Sulphate, Chloride, Carbonate and Ferrous iron. 
 On the basis of acute toxicity Results the study shows that SANGU PARPAM  
did not produce any toxic Efficacy for the dose of 2000mg/kg to rats. 
 On the basis of subacute toxicity Results, the study reveals that SANGU 
PARPAM  did not cause either any lethality or adverse changes with general 
behaviour of rats and also there were no observable detrimental effects (200 to 
600mg/kg body weight) over a period of 28 day. 
 In histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
 Haematological analysis revealed no abnormalities attributable to the 
treatment. 
 These results indicate that SANGU PARPAM  upto 200-600mg/kg body 
weight no changes occured. 
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SUMMARY 
 
 The medicine SANGU PARPAM  was taken for the dissertation work based 
on  Dr. R. Thiyagarajan, L.I.M., Gunapadam Thathu Jeevam,  2013;            
Pg. No. 646. 
 The aim of this dissertation is to study the acute and sub-acute toxicity of the 
medicine SANGU PARPAM  administered at various presumed moderate 
dosage, in the experimental animals. 
 The Ingredients of SANGU PARPAM  are Sangu and Keezhanelli.  The sangu 
were purchased from fishermen of Tiruchendur Seashore and Keezhanelli 
collected from Moolikulam region. 
 The raw samples were taken for purification and the test medicine was 
prepared, as per the method narrated in the literature. 
 The drug was analysed for its physicochemical properties and contents by 
using qualitative biochemical analysis and modern techniques such as 
inductively couped plasma-optical emission spectrometry. 
 Depending upon the result of these analysis the contents of test sample was 
identified. 
 By scanning electron microscope (SEM), the size of the particles about                    
0.5-2 micron, were analyzed. 
 The study was done at Department of  Pharmacology, Arulmigu Kalasalingam 
University, Krishnankovil, Virudhunagar District. 
 To evaluate the acute toxicity study 15 rats were selected and divided into                        
5 groups (Group I,II,III,IV,V) and they were administered with the drug with 
different graded doses ranging from Control, 5mg/kg, 50mg/kg, 300mg/kg and 
2000mg/kg.  Body weight animal orally with control group.  Daily the animals 
were observed for clinical signs and mortality.  The drug did not produce any 
mortality and is safe upto 2000mg/kg body weight. 
 Sub acute Toxicity was conducted for about 28 days duration.  No signs of 
toxicity was observed in animals from different dose groups during the dosing 
period. 
 The haematological index shows no significant changes 
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 During long term administration of the drugs at both low dose and high dose 
SGOT, SGPT, Serum Urea, Serum Creatinine level found to be within the 
normal range. 
 There is no remarkable histopathalogical changes. 
 Biostatistical measures to the acute and subacute toxicity studies shows the 
drugs “SANGU PARPAM ” found to be safe up to  2000mg/kg body weight 
of the animal in acute toxicity study and found to be safe upto 600mg/kg body 
weight of the animal in sub-acute toxicity study. 
  In this study since there is no mortality, the lethal dose of drug could not be 
calculated  
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CONCLUSION 
 
From acute toxicity study it was observed that the administration of SANGU 
PARPAM  up to the  dose of 2000 mg/kg to the Wistar Albino Rats did not produce 
drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level (NOAEL) 
of SANGU PARPAM  is 2000 mg/kg. 
 
The subacute toxicity studies also reveals that the drug “SANGU PARPAM” 
can be considered safe, as it did not produce either any lethality or adverse changes 
with general behaviour of rats and also there were not observable determental effects 
in the doses (200 to  600 mg/kg body weight)  over a period of 28 days.  It is 
concluded that the “SANGU PARPAM ” is relatively  safe in long administration 
upto the dose of 600mg/kg. 
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